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ABSTRACT 
 
Over the last decade the number of Canadians with end-stage kidney disease (ESKD) 
has steadily risen and there are at present more than 35,000 Canadians living with 
ESKD. Currently only three treatment options are available to replace the blood filtering 
function performed by the kidneys: hemodialysis, peritoneal dialysis and kidney 
transplant. A better understanding of the mechanisms involved in kidney development 
could hold the key to developing targeted therapies to repair and reverse damage caused 
by kidney diseases.  
 
The DNA-binding transcription factor Wilms' Tumor Suppressor-1 (WT1) plays an 
essential role in nephron progenitor cell differentiation during kidney development. In 
mice, homozygous deletion of Wt1 results in complete absence of both kidneys. 
Previously, chromatin-immunoprecipitation coupled to microarray identified all three 
members of the Sry-related high-mobility group (HMG) Box (Sox)C subfamily, namely, 
Sox4, Sox11 and Sox12, as novel Wt1 target genes that may regulate kidney 
development in vivo. Although SoxC genes play master roles in determining neuronal 
and mesenchymal progenitor cell fate in a multitude of developmental processes, their 
function in the developing kidney has been, until now, undefined.  
 
All three SoxC genes are expressed in the nephrogenic lineages during kidney 
development. Conditional ablation of Sox4 in nephron progenitors and their cellular 
descendants (Sox4neprhon- mice) results in early-onset proteinaceous glomerular injury 
within 2 weeks of birth progressing to end-stage renal failure within 5-9 months. An 
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updated version of the gold standard modality to accurately, rapidly and cost-effectively 
quantitates nephron number in embryonic and post-natal mouse kidneys was developed. 
This approach was used to determine that ablation of Sox4 in nephron progenitors and 
their cellular descendants results in a significant reduction in nephron endowment.  
This reduction in nephron endowment in Sox4neprhon- mice results from the formation of 
fewer pretubular aggregates, likely as a result of decreased cell cycling of nephron 
progenitor cells. Sox4 and Sox11 were also shown to be dispensable for normal podocyte 
differentiation and function. Conditional deletion of both of these genes individually as 
well as in combination in podocytes resulted in no apparent glomerular phenotype after 6 
months and does not recapitulate the phenotype observed in Sox4neprhon- kidneys. Analysis 
of Sox4neprhon- kidneys suggests that the genesis of glomerular injury may be activated 
parietal epithelial cells (aPEC).  
 
Collectively, the results presented in this thesis demonstrate that Sox4 plays multiple 
crucial roles in normal kidney development and function in vivo.  
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1. General Introduction 
The kidney is an essential organ. Its primary function is the removal of waste from the 
bloodstream as well as the regulation of electrolytes and water. Unlike many other organ 
systems in the body, such as the skin, intestine, lungs, and liver, which undergo constant 
cellular turnover (Pellettieri and Sánchez Alvarado 2007), a population of adult stem 
cells has not as of yet been definitively identified in the kidney that is maintained 
following the completion of kidney development. The continued identification and 
understanding of fundamental processes which underlie the development of a 
functioning kidney is crucial to understand the etiology of diseases and to identify 
potential therapeutic targets for their treatment. 
 
Nephrogenesis is the production and development of nephrons in the kidney. Following 
its completion, the number of nephrons present, referred to as nephron endowment, is 
set for a given individual. Nephron endowment varies greatly within human and animal 
populations, ranging from 7,000 to 20,000 in mice (Cebrian et al. 2004, Murawski et al. 
2010, Zhong et al. 2012), and from 200,000 to 2 million in humans (Hughson et al. 
2003, Hoppe et al. 2007, Bertram et al. 2011). Once nephrogenesis is complete (at 34-36 
weeks of gestation for humans and postnatal day 7-10 for mice), the number of nephrons 
will not increase over the course of an individual’s life, but may decrease as a result of 
injury or insult. An increasing body of evidence now links low nephron endowment to 
poor long-term health outcomes and adult-onset hypertension (Keller et al. 2003, Reyes 
and Mañalich 2005, Walker et al. 2012).  
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Because nephrogenesis occurs largely during embryonic development, an increased 
understanding of the fundamental signaling pathways and events that underlie 
embryonic kidney development are essential. This knowledge will lay a foundation for 
new therapies and stem cell-based strategies aimed at kidney regeneration to prevent 
and reverse the effects of kidney disease. This increased understanding also has the 
potential to identify better therapeutic targets for the treatment of kidney disease.  
 
1.1 End Stage Kidney Disease and Treatments 
1.1.1 Canadian Statistics 
According to the Canadian Institute for Health Information, more than 35,000 
Canadians (excluding Quebec) were living with end-stage kidney disease (ESKD) in 
2014, with 58% of those patients receiving some form of dialysis (CIHI 2016). Over 
5,200 new Canadian patients were also diagnosed with ESKD in 2014, a number which 
continues to rise from year to year. Diabetes was the main cause of ESKD in 
approximately 36% of newly diagnosed patients (CIHI 2016). Diabetic nephropathy is 
rapidly becoming the major cause of cardiovascular mortality and ESKD worldwide 
(Khan and Quaggin 2015). Dialysis represents a substantial financial burden to the 
Canadian health care system, with the annual cost being approximately $60,000 per 
patient. Dialysis also has a substantial impact on the overall quality of life of the patient, 
with standard haemodialysis regiments consisting of several multiple hour sessions per 
week. It is estimated that over a five-year period, a single kidney transplant saves the 
Canadian health care system more than $250,000, while also significantly improving the 
quality of life of the patient. Unfortunately, not all patients are eligible for a transplant 
and some of those that are can spend years on a waiting list. Between 2005 and 2014, 
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the waiting list in Canada for kidney transplants remained approximately 2.5 times 
longer than the number of transplant surgeries performed (CIHI 2016).  
 
1.1.2 Treatment for ESKD 
Proteinuria, the presence of abnormal amount of protein in urine, fibrosis and 
endothelial injury all contribute to ESKD. Left untreated ESKD will lead to coma, 
seizures and death. There are currently only three treatment options to replace the vital 
life maintaining blood filtering function performed by the kidneys which is lost during 
ESKD. The three treatments are i) hemodialysis, ii) peritoneal dialysis and iii) kidney 
transplant. A fourth option that may be pursued is conservative management, where the 
focus is on using medication and diet to keep the patient comfortable and to treat the 
resulting issues of ESKD such as anemia, edema and pain. Although none of the four 
treatment options focus on repairing damage to the kidneys, they aim to improve the 
quality of life of the patient. With an ever increasing proportion of ESKD resulting from 
diabetic nephropathy, a substantial body of research is focused on novel agents aimed at 
targeting molecular pathways that may arrest rather than simply slow the progression of 
ESKD (Khan and Quaggin 2015). 
 
Dialysis involves the diffusion of molecules in solution across a semipermeable 
membrane along a concentration gradient. The primary purpose of hemodialysis 
(dialysis of the blood) is the removal of metabolic waste and excess fluid from the 
circulating bloodstream in order to restore the intracellular and extracellular fluid 
environment that is present when kidney function is normal (Himmelfarb and Ikizler 
2010). In essence, it acts as a long term kidney replacement by substituting for some of 
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the functions of the kidney and reducing the impact of the side-effects accompanying 
loss of kidney function. To accomplish this end, the patient’s blood is pumped through a 
machine called a dialyser wherein solutes including urea, a toxic by-product of protein 
catabolism, are transported from the blood into the dialysate and solutes such as 
bicarbonate are transported from the dialysate into the blood (Figure 1.1) (Himmelfarb 
and Ikizler 2010).  
 
Although hemodialysis has come a long way in the last several decades, due in large 
part to technical and technological advances, much research continues in the field. The 
usual treatment regime for in-center hemodialysis in North America is 4 hour sessions, 3 
times a week. Increases in both time and frequency of treatments have shown 
improvements in solute and fluid removal (Himmelfarb and Ikizler 2010). Quality of life 
issues continue to be better addressed in part by the increased accessibility of in-home, 
rather than in-center, hemodialysis (Weinhandl et al. 2016). 
 
Peritoneal dialysis is the second treatment option and gets its name from the use of the 
peritoneal cavity as the place of exchange for waste products out of the bloodstream. In 
peritoneal dialysis, rather than diverting the patient’s blood out of the body into a 
dialyser, the dialysate is infused into the patient’s abdomen via a permanent catheter. 
The dialysate remains in the abdomen for several hours during which time waste 
products diffuse across the peritoneum from the underlying blood vessels. Following the 
treatment period, the dialysate containing waste products is drained off and replaced 
with fresh dialysate (Figure 1.1). Although peritoneal dialysis offers many advantages 
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Figure 1.1. Comparison of dialysis modalities. In hemodialysis (top), blood is pumped 
through a dialyser where waste products are removed. In peritoneal dialysis (bottom), 
the dialysate is infused into the peritoneal cavity where it remains for several hours and 
is then drained along with waste products which diffuse from the underlying 
vasculature. 
 
 
over hemodialysis, including in most cases lower associated costs (Bargman 2012), 
lesser requirement of highly trained personnel and infrastructure or equipment and 
general increase in freedom and improved quality of life of the patient, it remains 
underutilised in many parts of the world due in large part to socio-economic reasons 
(Abraham et al. 2015). Although peritoneal dialysis offers more flexibility and freedom 
to the patient in many regards, some patients also find the daily replacement of dialysate 
disruptive and disruption of the abdominal catheter can lead to peritonitis.  
6 
 
 
Finally, a transplanted kidney is considered by far the best option both financially and in 
terms of quality of life. A kidney from a living donor or a cadaver now has an average 
lifespan of 8-15 years depending on the type of graft (Thiruchelvam et al. 2011). More 
than 30% of living donors of kidneys are currently categorized as unrelated to their 
recipient. In order to avoid hyperacute rejection, protocols that desensitize and 
immunosuppress the recipient are now well established (Davis and Delmonico 2005). 
The main complications following transplant are rejection and infection, and 
maintenance immunosuppression is an ongoing requirement to prevent graft rejection. 
Although the transplant recipient will be closely followed and monitored for risk factors, 
including those of cardiovascular disease, the quality of life of a transplant patient is 
drastically improved. There are also many significant socioeconomic factors 
surrounding kidney transplants. Many countries in the world exploit their poor to supply 
kidneys for transplant. With a significant and maintained increase in “transplant 
tourism” and organ trafficking, participants in the International Summit on Transplant 
Tourism and Organ Trafficking held in Istanbul, Turkey in 2008 established The 
Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Their hope being 
that “The legacy of transplantation must not be the impoverished victims of organ 
trafficking and transplant tourism but rather a celebration of the gift of health by one 
individual to another” (ISTTOT 2008). 
 
There are also many groups working towards a wearable artificial kidney, which is not 
without its challenges. Conventional haemodialysis units usually weigh upwards of 
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60kg and also require a separate unit to purify the 120L of water that are required per 
session (Kooman et al. 2015). Finding ways to overcome the technical challenges 
associated with creating a device that is small enough to wear, functions adequately, is 
safe and will be adopted by the patients is not an easy task. Silicone nanopore 
membranes have recently been manufactured to serve as hemofilters for an implantable 
renal assist device (Kim et al. 2015). Other risks and challenges associated with a 
wearable kidney arise from the need for direct access of the device to the bloodstream, 
with the possibility of considerable blood loss or an air embolism in the case of an 
accidental disconnection (Kooman et al. 2015).  
 
1.1.3 Stem Cell Based Therapies 
Stem cells have been classically defined as the undifferentiated cells of a multicellular 
organism with extensive renewal capacity and the ability to generate daughter cells that 
undergo further differentiation (Watt and Driskell 2010). The general shift in interest 
towards stem cells is a focus on how adult tissue is maintained and repaired rather than 
how tissues arise during development in the embryo. Multiple studies have identified 
cell proliferation and some restoration of kidney function in animal models following 
ischemia. There is increasing evidence, although still debated, that podocyte and tubular 
progenitor cells exist that can to some extent replace damaged cells (Romagnani 2013, 
Romagnani et al. 2013, 2015). The controversial search for a renal stem cell continues 
and, to date, none have been identified that possess the indefinite capacity for 
self-renewal that in part defines a stem cell (Little and Bertram 2009, McCampbell and 
Wingert 2012, Endo et al. 2015). Various applications of embryonic stem cells, renal 
progenitor cells as well as induced pluripotent stem cells of various origin have been 
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pursued as a means to regenerate and repair kidney damage (Song et al. 2012, Yokote et 
al. 2012, Chou et al. 2014, Lam and Morizane 2015, Little and Takasato 2015, Suzuki et 
al. 2016). 
 
Stem-cell based therapies which could allow for regeneration and preventative measures 
to kidney damage from disease will no doubt have far reaching implications and the 
potential to revolutionize the treatment of kidney disease (Yokoo et al. 2007, 2011). 
These strategies are still in their infancy and require a better understanding of kidney 
development at the cellular and molecular level, under both physiologic and pathologic 
conditions. Therapeutic targets will be identified as we continue to better understand 
how the same mechanisms involved in kidney development can be applied and targeted 
to repair kidney damage. 
 
1.2 Kidney Development 
Through the use of transgenic animals, much has been learned in the past decades about 
the molecular and cellular events that give rise to a fully functional kidney (For recent 
reviews see Costantini and Kopan 2010, Little et al. 2010, Rumballe et al. 2010, Little 
and McMahon 2012). However, it is clear that not all the players in the molecular 
pathways involved have been identified. 
 
Kidney development results from the reciprocal signalling and interaction of the 
metanephric mesenchyme (MM) and the ureteric bud (UB) both of which are derived 
from the intermediate mesoderm (For a recent review see McMahon 2016). Briefly, at 
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embryonic day (E)10.5 in the mouse, factors secreted from the MM act on receptors in 
the UB and the UB subsequently invades the MM. At E11.5 the UB forms a T-shaped 
bifurcation and, in response to further signalling from the MM, will undergo several 
rounds of bifurcation and elongation which will ultimately result in the formation of the 
collecting duct system of the kidney (Dressler 2006). In parallel, signals from the UB 
induce the mesenchymal cells to condense around the ureteric bud tips as Six2 positive 
nephron progenitor cells (NPC) around the cap mesenchyme. These cells will 
subsequently proliferate and differentiate into pre-tubular aggregates which will, 
following mesenchymal-to-epithelial transition (MET), sequentially give rise to renal 
vesicles, comma-shaped and S-shaped bodies (S-SB) and finally functional nephrons 
(Kuure et al. 2000) (Figure 1.2). In the S-SB stage, the most distal portion of the S-SB 
unfolds and the lumen becomes continuous with the ureteric stalk, while the proximal 
cleft will be infiltrated by endothelial cells and form the glomerular tuft.  
 
The functional subunit of the kidney is the nephron and each renal vesicle gives rise to a 
nephron. The renal corpuscle is composed of four primary cell types: endothelial cells, 
of the glomerular capillaries, intraglomerular mesangial cells, podocytes and parietal 
epithelial cells (Figure 1.3). The fenestrated endothelial cells of the capillaries form a 
primary component of the glomerular filtration barrier and allow proteins and fluid 
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Figure 1.2. Schematic representation of the development of a nephron. A) Signaling 
from the ureteric bud tip causes the Six2+ cap mesenchyme to condense to form 
pretubular aggregates (not illustrated) which further differentiate and undergo 
mesenchymal-to-epithelial transition (MET) to form the renal vesicle (RV). The 
epithelial and polarized RV transitions through the comma-shape body (not illustrated) 
to the S-shape body (S-SB) to form the functioning nephron. B) The functional nephron. 
Colour coding indicates speculative cell lineage fate. Adapted from McMahon 2016. 
 
 
to pass from the glomerular tuft to the urinary space. Mesangial cells provide physical 
support, elasticity and structure to the glomerular tuft. They also secrete extracellular 
matrix and act as pericytes to help regulate blood flow through the capillaries. 
Podocytes are highly specialized epithelial cells that cover the glomerular capillaries, 
representing the visceral layer of Bowman’s capsule. Sandwiched between the 
podocytes and the fenestrated endothelium of the capillaries is the glomerular basement 
membrane (GBM). A unique characteristic of the podocyte is the network of 
interdigitated foot processes and slit diaphragms that along with the GBM and 
underlying fenestrated endothelium make up the glomerular filtration barrier (Barisoni 
and Mundel 2003). As the ultrafiltrate travels through the glomerular filtration barrier it 
enters the urinary space of Bowman’s capsule. The urinary (Bowman’s) space is 
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surrounded by the parietal epithelium and feeds into the lumen of the proximal tubule.  
 
 
 
 
Figure 1.3. Schematic representation of the renal corpuscle. The blood enters the 
glomerular capillaries (*) from the vascular pole (VP). The fenestrated endothelium of 
the capillaries, glomerular basement membrane (black) and podocytes (Pod, blue) with 
slit diaphragms are the three components that make up the glomerular filtration barrier. 
The mesangial cells (shaded) provide physical support to the capillaries and also play a 
role in regulating blood flow. The parietal epithelial cells (PEC, red) encapsulate 
Bowman’s space (BS) which is continuous at the tubular pole (TP) with the proximal 
tubule. Adapted from Appel et al. 2009. 
 
 
Many of the specific molecular pathways involved in the maintenance of nephron 
progenitor cells, ureteric bud branching and proper nephron formation have been 
identified and continue to be elaborated.  
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Osr1 is one of the earliest markers of kidney progenitor cells in mice and has been shown 
to be upstream of other factors essential for normal kidney development including Eya1, 
Pax2, Six1 and Six2, WT-1 and Gdnf (James et al. 2006). Osr1 knockout mice fail to form 
intermediate mesoderm, resulting in renal agenesis. These animals die embryonically 
with cardiac defects (Wang et al. 2005). More recently Osr1 has been placed in a network 
of transcriptional regulators that mediate podocyte differentiation (Tomar et al. 2014) and 
shown to act synergistically with Wt1 to regulate nephron endowment (Xu et al. 2016).  
 
Crucial to the proper formation of the outgrowth of the UB is the Gdnf/Ret pathway. Gdnf 
is secreted by the MM and acts on the Ret receptor-tyrosine kinase on the UB, which in 
turn triggers the outgrowth of cells towards the GDNF signal (Costantini 2010b). Many 
other pathways play critical roles in UB branching and MM differentiation, including 
bone morphogenic protein, sonic hedgehog, and fibroblast growth factors (Chai et al. 
2013). Wnts have also been shown to play important roles in renal vesicle formation as 
well as in branching morphogenesis (Merkel et al. 2007). 
 
Wnt9b and Wnt4 are known to play crucial roles in renal vesicle formation, while 
Wnt11 regulates UB branching by maintaining normal GDNF levels (Pepicelli et al. 
1997, Merkel et al. 2007).  Specifically signalling through β-catenin is essential for 
normal branching and maintenance of UB tip progenitor cell identity (Bridgewater and 
Rosenblum 2009, Little and McMahon 2012, Boivin et al. 2015). β-catenin has also 
been shown to play an essential role in the self-renewal of nephron progenitor cells 
(Karner et al. 2011, Sarin et al. 2014). 
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Advances in molecular biology techniques and approaches continue to increase our 
understanding of various genetic pathways in the kidney, in part by specifically 
targeting various cell types in the kidney (Kohan 2008, 2015). Defects in nephrogenesis 
and ureteric branching result in congenital anomalies of the kidney and urinary tract 
(CAKUT). These pleiotropic malformations comprise a multitude of renal phenotypes 
including renal agenesis, hypoplasia, and renal dysplasia, associated with obstructive or 
reﬂuxive anomalies of the ureter (Toka et al. 2010). Congenital anomalies of the kidney 
and urinary tract are predicted to have different genetic origins (Weber 2012), yet the 
molecular pathogenesis of CAKUT is not well understood. Nephron deﬁciency is also a 
hallmark feature of CAKUT (Puddu et al. 2009). Our increased understanding of normal 
kidney development continues to set the stage for better appreciation of the pathogenesis 
of kidney disease and to allow for more comprehensive treatment strategies.  
 
1.2.1 Nephron Number 
An increasing body of evidence now links nephron endowment to long-term health. 
More recently, reduced nephron number has been hypothesized to constitute a “factor of 
vulnerability” which is insufficient by itself, however in combination with additional 
factors, can result in the early onset of renal diseases (Boubred et al. 2013). Early 
postnatal nutrition, including sodium intake as well as protein or caloric intake, along 
with early postnatal growth exert a considerable influence on adult health. Overfeeding 
and rapid postnatal growth both enhance the vulnerabilities acquired in utero and 
accelerate the development of adult diseases (“mismatch hypothesis”) (Boubred et al. 
2013). Almost three decades ago, Brenner et al. (1988) proposed that a decrease in the 
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total filtration surface resulting from reduced nephron number is associated with an 
adaptive increase in single nephron glomerular filtration rate (snGFR). This increase in 
snGFR in turn results in further adaptations including glomerular and tubular 
enlargement and elevated blood pressure levels (Brenner et al. 1988). 
 
The principal determining factor associated with nephron number is birth weight but it is 
not the sole factor (Hughson et al. 2003). An increasing body of experimental evidence 
shows that low birth weight and reduced nephron number can occur independent of each 
other and do not always result in adult hypertension (Mitchell et al. 2004). It has also 
been shown that maternal dietary protein restriction leads to reduced glomerular 
number, impairment of renal development and programs for salt-sensitive adult 
hypertension in rodents (Woods et al. 2004). Using a mouse model, Walker et al. (2012) 
showed that increased nephron endowment protects against salt-induced hypertension. 
Other factors of significant influence include the timing and nature of in utero insults, 
such as excessive glucocorticoid exposure or maternal malnutrition, the gender of the 
fetus and the postnatal environment (Moritz et al. 2003, Moritz and Bertram 2006, Benz 
and Amann 2010). Variability in nephron endowment may be explained in part, by 
genetic and environmental factors as well as the interaction between the two. 
 
Glomerular volume varies inversely with glomerular number. Larger glomeruli may be 
a sign of compensatory hyperfiltration and hypertrophy in individuals with fewer 
nephrons. Based on this observation, it has been suggested that when kidney damage 
occurs, the total filtration surface area may initially be maintained. However, the 
accompanying glomerular hypertrophy is a predictor of poorer outcomes 
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(Douglas-Denton et al. 2006, Zandi-Nejad et al. 2006), such as systemic hypertension, 
albuminuria, and reduced glomerular filtration rate (GFR) culminating in ESKD 
(Schreuder 2012).  
 
In order to quantify nephron number, multiple approaches have been developed, the 
most accurate and unbiased being the application of stereology. The application of 
stereology, both technical and theoretical, to kidney research has been covered at length 
elsewhere (Nyengaard 1999, Cullen-McEwen et al. 2012a, 2012b, Puelles et al. 2014, 
Puelles and Bertram 2015). Stereological techniques can be used not only for counting 
nephrons and other cell types found in the kidney, but can also be applied to make 
unbiased volumetric measurements. Tissue shrinkage as well as other deformations, 
including expansion of the paraffin embedded section when floated on a hot water bath, 
make it impossible to obtain unbiased and accurate measurements of volume without the 
use of plastic polymers as embedding medium and utmost consistency in technical 
protocols. 
 
Much still remains to be discovered in our understanding of the complex relationship 
between nephron endowment, hypertension and kidney disease. Various studies have 
shown that reduced nephron number, especially when it is moderate, is not 
systematically associated with impaired GFR and hypertension (Zimanyi et al. 2004, 
Hughson et al. 2006, Boubred et al. 2009). Many studies suggest that the relationship 
between nephron number, hypertension and kidney disease is quite complex and 
multifaceted. The clinical outcome depending not only on the severity of reduced 
nephron endowment, but also the degree of increased snGFR (Moritz et al. 2009, 
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Boubred et al. 2013). Multiple genes have been identified that are linked to an 
impairment of nephron development in humans. Some are associated with a reduction in 
the number of nephrons and kidney size, such as PAX2, which is associated with renal 
coloboma, while others, such as EYA1, are associated with more severe renal agenesis 
(Dötsch et al. 2009).  
 
1.3 Sox Genes 
Sry-related high-mobility group (HMG) Box (Sox) genes are a family of transcription 
factors characterized by the HMG domain, which is a DNA-binding domain shown to 
interact with the minor groove of the DNA helix. Although often studied in isolation, 
the binding of transcription factors to their regulatory sequences are but a single event in 
a series of complex interactions that ultimately regulate gene expression (Spitz and 
Furlong 2012, Huang et al. 2015). The resolved crystal structures of various HMG 
domains from the Sox family of transcription factors has increased our understanding of 
the conformations that allow for preferential binding to DNA sequences (Jauch et al. 
2012). All Sox proteins recognize and bind the DNA consensus motif A/TA/TCAAA/T. 
This sequence is short and degenerate and found in abundance throughout the genome. 
Although flanking sequence preferences have also been identified for many of the SOX 
proteins, such that the position weighted consensus sequence for SOX4 binding is 
AACAAA/TG/AG/A (Scharer et al. 2009), other factors must be involved in assigning 
specificity of recognition for a given SOX protein to the appropriate sequence. The 
activity of Sox proteins is essentially dependant on their DNA-binding properties, 
however their ability to bind to the appropriate DNA sequences is also dependant on 
their interactions with other transcription factors and co-factors (Wegner 2010). 
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Sox genes are differentially expressed over time and in various compartments 
throughout development of multiple organ systems (Wegner 1999, Watanabe et al. 
2016). Mammalian Sox genes are divided into eight subfamilies (A-H) based on 
phylogenetic homology of their HMG box domain (Kiefer 2007). The Sox family of 
transcription factors have been shown to control stem cell self-renewal and stem cell 
differentiation in a multitude of developmental processes (Sarkar and Hochedlinger 
2013), including stemness (Avilion et al. 2003), male differentiation (Koopman et al. 
1991, Foster and Graves 1994, Schepers et al. 2003, Chaboissier et al. 2004, Koopman 
2005), neurogenesis (Graham et al. 2003, Episkopou 2005) and gliogenesis (Kuhlbrodt 
et al. 1998a, 1998b), neural crest (Hong and Saint-Jeannet 2005) and spinal cord 
development (Shim et al. 2012), cardiac outflow tract (Schilham et al. 1996) and B-cell 
development (Wetering et al. 1993), as well as skeletogenesis (Zhao et al. 1997, 
Lefebvre et al. 1998, Lefebvre and Smits 2005, Lefebvre and Bhattaram 2016) in vivo. 
 
Members of a given Sox subfamily are often found co-expressed with each other in 
developing tissues and have been shown to exhibit overlapping functions. Accordingly, 
the three SoxC subfamily members Sox4, Sox11 and Sox12 exhibit overlapping 
expression patterns in many developing tissues during embryonic development (Dy et 
al. 2008), and essential overlapping functions of Sox4 and Sox11 have been 
demonstrated in neural progenitor cell survival and differentiation during organogenesis 
in vivo (Thein et al. 2010, Shim et al. 2012, Mu et al. 2012). Sox4 has also been 
identified to play multiple roles in and is correlated with a variety of tumours 
(Jafarnejad et al. 2013, Vervoort et al. 2013), including leukemia (Zhang et al. 2013), 
18 
 
pancreatic cancer (Huang et al. 2012), lung cancer (Castillo et al. 2012), breast cancer 
(Tiwari et al. 2013) and colorectal cancer (Andersen et al. 2009), while Sox11 has been 
identified in association with mantle cell lymphoma (Lu et al. 2013) as well as gastric 
cancer (Qu et al. 2014). 
 
Sox4 knockout mice die at E14 from a defect in cardiac outflow tract formation 
(Schilham et al. 1996), while Sox11 knockout mice die shortly after birth with a similar, 
although less severe, malformation of the heart (Sock et al. 2004). Sox12 knockout mice 
on the other hand are viable and fertile and do not appear to have any defects (Hoser et 
al. 2008). It has been shown, by evaluating combinations of heterozygous, double- and 
triple-knockout mice, that the three SoxC genes interact functionally with each other 
during organogenesis and that functional redundancy exists between the three SoxC 
genes in vivo in a multitude of developmental processes (Bhattaram et al. 2010). Of the 
three SoxC genes, SOX12 has been shown to be the weakest transactivator in vitro 
(Hoser et al. 2008), and most recent studies of SoxC gene function have focused only on 
Sox4 and Sox11. 
 
1.3.1 Sox Genes in the Kidney 
Multiple studies have reported on the presence of a Sox gene being expressed in the 
kidney without further follow-up or investigation. Takash et al. (2001) detected mRNA 
expression of Sox7 and Sox18 in the kidney by Northern Blot. The signal was not very 
strong compared to other tissues or embryonic stages but was nonetheless present 
(Takash et al. 2001). Moderate levels of Sox18 expression were also detected in the 
kidney by RT-PCR by Hosking et al. (2001). By whole mount in situ hybridization, 
19 
 
Sox8 was shown to be expressed in the kidney at E13.5 at the tips of the ureteric trees 
(Schepers et al. 2000) and multiple groups have also identified the expression of Sox13 
in the kidney (Kido et al. 1998, Roose et al. 1998, Kasimiotis et al. 2000).  
 
Still other studies have linked the expression of Sox genes to the development of 
diabetic nephropathy and other defects in kidney development. Sox17 expression was 
found to be decreased in the early phase of diabetic nephropathy in a murine model 
(Wada et al. 2001) and mutations in Sox17 are also associated with CAKUT in humans 
(Gimelli et al. 2010, Combes et al. 2012). Matsui et al. (2006) provided evidence of 
functional redundancy of Sox17 and Sox18 in vascular endothelial cells by generating 
double mutant mice. Specifically they demonstrated that although Sox18-/- and Sox17+/-; 
Sox18+/- double transgenic mice presented no vascular defects, by removing an 
additional allele approximately half of the Sox17+/-; Sox18-/- mice die before postnatal 
day (P)21 due to reduced neovascularization of the liver and kidney as a result of 
defective endothelial remodeling (Matsui et al. 2006). These experiments demonstrate 
that in the total absence of Sox18, Sox17 is able to fill in for Sox18 with no apparent 
changes in the phenotype.  
 
Sox8, Sox9, and Sox10 make up the SoxE subfamily of transcription factors. The SoxE 
subfamily has been shown to play multiple roles in various cell types during kidney 
development. Sox9 plays a role in the regulation of α2(IV) collagen in mesangial cells 
(Sumi et al. 2007), and as a result of signaling, also induces a chondrogenic phenotype 
of mesangial cells during diabetic nephropathy (Kishi et al. 2011). Recently two groups 
have shown that Sox9 activation is an early transcriptional response to acute kidney 
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injury which is required for normal proximal tubular repair after acute ischemic kidney 
injury. Sox9 positive progenitor cells also contribute to epithelial regeneration following 
injury (Kumar et al. 2015, Kang et al. 2016). 
 
In 2001 Sock et al. generated Sox8 knockout mice by replacing the endogenous Sox8 by 
the LacZ reporter gene and a neo cassette. The LacZ gene codes for the β-galactosidase 
enzyme and its expressions allows for the easy identification of cells where it is 
expressed through incubation with the X-Gal substrate resulting in a blue precipitate. 
This replacement allowed not only inhibition of the expression of Sox8, but also use of 
the LacZ marker to identify the location of endogenous Sox8 (Sock et al. 2001). The 
resulting mice were viable, fertile, and had a substantial weight reduction, however they 
failed to exhibit any major developmental defects in any of the organs where Sox8 is 
expressed. Although there was no compensatory increase in Sox9 or Sox10 expression, 
the mild phenotype in the absence of Sox8 could at least in part be due to functional 
redundancy between the three proteins. With the expression LacZ in various organs, 
including the kidney, Sox8 was identified and tracked over time. Expression of Sox8 in 
the kidney starts at the tip of the ureteric tree and from E14.5 onward it is restricted to 
the glomeruli and proximal tubules. At the conclusion of nephrogenesis, the expression 
of Sox8 rapidly decreases and is not detectable in the adult kidney (Sock et al. 2001). 
More recently, Sox8 and Sox9 have been shown to play an important role in ureteric 
branching during kidney development. Using two conditional knockouts strains, Airik et 
al. (2010) demonstrated that the absence of Sox9 expression in the undifferentiated 
ureteric mesenchyme resulted in hydroureter due to a functional obstruction. There was 
no effect on condensation, proliferation and apoptosis of the undifferentiated 
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mesenchyme (Airik et al. 2010). Sox9 acts at multiple steps during kidney development, 
and significantly acts with Sox8 to regulate epithelial branching morphogenesis of the 
ureter. Sox9 also maintains ureteric tip identity. In the absence of Sox9 ectopic nephron 
formation occurs in the outer cortex of the kidney (Reginensi et al. 2011). These data 
taken together indicate a significant role for the SoxE subfamily of transcription factors 
in kidney development and maintenance.  
 
Prior to the research presented in this thesis, very little has been known of the role of 
SoxC in kidney development. SOX11 and WT1 proteins have been immunoprecipitated 
together in protein extracts from embryonic mouse kidneys using an anti-SOX11 
antibody, suggesting that they interact in vivo (Murugan et al. 2012). Morpholino 
mediated knockdown of wt1 or sox11 also inhibited the expression of the epithelialization 
factor wnt4 in the pronephros of Xenopus embryos (Murugan et al. 2012). In 2000, Plisov 
et al. published the results of a differential display experiment in which they induced rat 
MM explants to either condense, or to form tubules. In this system, Sox11 was identified 
as one of the novel sequences found to be increased during MET in the kidney. They 
also confirmed, with in situ hybridization, the findings of their differential display and 
found that Sox11 was most markedly expressed in the newly formed epithelial structures 
of the S- and comma-shaped bodies (Plisov et al. 2000). Although Murugan et al. (2012) 
were able to show physical interaction of WT1 and SOX11 proteins in a complex in the 
developing murine kidney at E13.5, there has been no direct evidence presented as to the 
role that Sox11 plays in the mammalian kidney. As noted above MET plays an important 
roles during normal kidney development, and it is interesting to note that Sox11 is 
upregulated during epithelial-to-mesenchymal transition (Kiemer et al. 2001, Venkov et 
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al. 2011) and that it has been identified by differential display in induced rat kidney 
explants during MET (Plisov et al. 2000). Further all three members of the SoxC 
subfamily (Sox4, Sox11, and Sox12) were identified as candidate Wt1 gene targets by 
ChIP-chip in E18.5 mouse kidneys (Hartwig et al. 2010). Taken together, this data 
suggests that the expression of SoxC in the mammalian kidney merits further 
investigation.  
 
1.4 Research Objective 
The purpose of this dissertation is to establish the role of Sox4 in kidney development 
with a particular focus on nephron progenitor cells. All experiments were carried out to 
test the working hypothesis that Sox4 is required for normal murine kidney development 
in vivo. I first sought to establish the expression profile of Sox4 during murine kidney 
development. As Sox4 knockout mice die embryonically prior to the completion of 
nephrogenesis, conditional knockout mouse models were further used to elucidate the 
role of Sox4 in nephron progenitor cells and podocytes.  
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2. The Transcription Factor Sry-Related HMG Box-4 (SOX4) is Required for 
Normal Renal Development in vivo 
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2.1 Abstract 
The DNA-binding transcription factor Wilms' Tumor Suppressor-1 (WT1) plays an 
essential role in nephron progenitor cell differentiation during renal development. 
Previously, chromatin-immunoprecipitation coupled to microarray (ChIP-chip) was 
used to identify novel WT1 target genes that may regulate nephrogenesis in vivo. It was 
discovered that all three members of the SoxC subfamily, namely, Sox4, Sox11 and 
Sox12, are bound by WT1in mouse embryonic kidneys in vivo. SoxC genes play master 
roles in determining neuronal and mesenchymal progenitor cell fate in a multitude of 
developmental processes, but their function in the developing kidney is largely 
unknown. Results from the present study show that all three SoxC genes are expressed 
in the nephrogenic lineages during renal development. Conditional ablation of Sox4 in 
nephron progenitors and their cellular descendants (Sox4neprhon- mice) results in a 
significant reduction in nephron endowment. By postnatal day (P)7, Sox4neprhon- renal 
corpuscles exhibit reduced numbers of WT1+ podocytes together with loss of 
expression of the slit diaphragm protein nephrin. Sox4neprhon- mice develop early-onset 
proteinaceous glomerular injury within 2 weeks of birth progressing to end-stage renal 
failure within 5-9 months. Collectively, these results demonstrate an essential 
requirement of Sox4 for normal renal development in vivo. 
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2.2 Introduction 
Kidney development begins at embryonic day (E)10.5 in mice, with the outgrowth of the 
ureteric bud from the Wolfﬁan duct into the overlying metanephric mesenchyme (for a 
recent review, see Little and McMahon 2012). In response to inducing signals from the 
ureteric bud, the metanephric mesenchyme condenses as a tight cap of nephron progenitor 
cells around ureteric bud tips, while the ureteric bud branches to form the collecting 
system. During nephrogenesis, nephron progenitors have the capacity to self-renew and 
to differentiate into pretubular aggregates, which in turn undergo mesenchymal-epithelial 
transition to sequentially form early renal vesicles, comma-shaped bodies, S-shaped 
bodies, and, ultimately, functional nephrons (Saxén and Sariola 1987, Self et al. 2006, 
Kobayashi et al. 2008).  
 
Defects in nephrogenesis and ureteric branching result in congenital anomalies of the 
kidney and urinary tract (CAKUT). With an incidence of 1:400 (Pope et al. 1999, 
Rumballe et al. 2010), CAKUT constitute one of the most frequent birth defects in 
humans, and the major cause of childhood renal failure. These pleiotropic malformations 
comprise a multitude of renal phenotypes including renal agenesis, hypoplasia, and renal 
dysplasia, associated with obstructive or reﬂuxive anomalies of the ureter (Toka et al. 
2010). CAKUT are predicted to have different genetic origins (Weber 2012), yet the 
molecular pathogenesis of CAKUT is not well understood. Nephron deﬁciency is a 
hallmark feature of CAKUT (Puddu et al. 2009). In fact, nephron number varies greatly 
even within normal range, from 7,000 to 20,000 in mice (Cebrian et al. 2004, Murawski 
et al. 2010, Zhong et al. 2012), and from 200,000 to 2 million in humans (Hughson et al. 
37 
 
2003, Hoppe et al. 2007, Bertram et al. 2011). Low nephron endowment within this 
normal range, though asymptomatic early in life, is associated with adult-onset 
hypertension (Mackenzie and Brenner 1995, Walker et al. 2012), a leading cause of 
coronary heart disease, stroke, and renal failure in North America (Tedla et al. 2011). 
Despite the fundamental importance of nephron endowment to health and disease, only a 
minority of molecular mechanisms underlying nephron morphogenesis have been 
identiﬁed. 
 
The Wilms’ Tumour Suppressor-1(WT1) gene encodes a DNA- and RNA-binding nuclear 
transcription factor that plays a critical role during nephrogenesis in part via its target 
gene effectors. However, endogenous gene targets that mediate WT1 function during 
renal development are largely unknown. Previously, WT1 ChIP-chip genome-wide 
location analysis was employed in embryonic E18.5 mouse kidney tissue, as a means of 
identifying novel kidney development genes that might act down-stream of Wt1 to 
control nephrogenesis in vivo (Hartwig et al. 2010). Intriguingly, all three members of the 
Sry-related high-mobility group (HMG) Box (Sox)-C subfamily—Sox4, Sox11, and 
Sox12—were identified as candidate WT1 gene targets by ChIP-chip. Members of the 
Sox gene family have been shown to play master regulatory roles in a multitude of 
developmental processes including dorso-ventral patterning (Chen et al. 2012), stemness 
(Avilion et al. 2003, Masui et al. 2007, Wang et al. 2012), male differentiation (Koopman 
et al. 1991, Wagner et al. 1994), neurogenesis (Bylund et al. 2003, Taranova et al. 2006, 
Bhattaram et al. 2010, Bergsland et al. 2011, Mu et al. 2012), cardiac outﬂow tract, 
B-lymphocyte (Schilham et al. 1996), and spinal cord development (Shim et al. 2012), 
and skeletogenesis (Akiyama and Lefebvre 2011, Lefebvre and Bhattaram 2016). 
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However, SOX function in the developing kidney is largely undeﬁned. 
 
Mammalian Sox genes are categorized into eight subgroups (A–H) based on phylogenetic 
homology of their HMG box DNA-binding domain. SOX proteins from different 
subgroups share partial identity (<46%) in their DNA-binding domain and none outside 
this domain. In contrast, subgroup members share a high degree of identity both within 
and outside their DNA-binding domains, thus often exhibiting functional redundancy in 
tissues where they are co-expressed. Accordingly, all three members of the SoxC 
subfamily— Sox4, Sox11, and Sox12—exhibit overlapping expression patterns in 
multiple tissues during embryonic development, suggesting genetic redundancy within 
this subfamily (Dy et al. 2008, Hoser et al. 2008). In this study, the renal developmental 
expression pattern of the three SoxC genes is characterized, and shown that strong Sox4 
expression is detected in nephron progenitors and their derivative nephrogenic structures, 
while Sox11 appears preferentially expressed in differentiating nephrogenic structures 
during renal development. To begin the investigation of SoxC function during 
nephrogenesis, Sox4 function was ablated in nephron progenitors and their cellular 
descendants (Sox4nephron- mice) using an established Six2Cre-EGFP transgenic line 
(Kobayashi et al. 2005, 2008). Postnatal Sox4nephron- kidneys exhibit signiﬁcantly reduced 
nephron number. Sox4nephron- mice exhibit reduced podocyte nephrin expression at P7, 
and develop severe proteinaceous kidney injury within 2 weeks of birth, leading to 
end-stage renal disease. Collectively, these results demonstrate an essential requirement 
for Sox4 in normal renal development, and further support a role for Sox4 in glomerular 
development and/or adult glomerular maintenance in vivo. 
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2.3 Materials and Methods 
2.3.1 Histology, Immunofluorescence, and RNA In Situ Hybridization 
For histology, postnatal (P) kidney tissues (P7 - Sox4nephron-  n=4, wild-type n=4; P16 - 
Sox4nephron-  n=7, wild-type n=7; Adult - Sox4nephron-  n=19, wild-type n=12) from male 
mice were ﬁxed in 10% neutral buffered formalin (Sigma-Aldrich, St. Louis, MO), and 
processed to form parafﬁn blocks in a Tissue-Tek VIP 6-A1 vacuum infiltration 
processor (Sakura Finetek, Torrance, CA) . The following program was used for tissue 
processing: Formalin 60 seconds, 70% EtOH 60 seconds, 70% EtOH 60 seconds, 95% 
EtOH 60 seconds, 95% EtOH 60 seconds, 95% EtOH 60 seconds, 100% EtOH 60 
seconds, 100% EtOH 60 seconds, xylene 90 seconds, xylene 90 seconds, paraffin 30 
seconds, paraffin 30 seconds, paraffin 30 seconds, paraffin 30 seconds. Tissues were 
sectioned at a thickness of 5 µm and subsequently stained with hematoxylin and eosin 
(H&E) and periodic acid-Schiff (PAS). For indirect immunoﬂuorescence, embryonic 
kidneys (Sox4nephron-  n=3, wild-type n=3) and postnatal (Sox4nephron- , n=3, wild-type 
n=3) kidneys were frozen in Tissue-TEK 4583 OCT compound (Sakura Finetek) in a 
liquid nitrogen cooled bath. To visualize nephrin expression, the kidneys were ﬁxed in 
4% paraformaldehyde (Sigma-Aldrich) at 4°C overnight before embedding in OCT 
compound. For all other antibodies, cryosections were ﬁxed in methanol 
(Sigma-Aldrich) at -20°C for 10 minutes. Immunoﬂuorescence staining on 4 midline 
4-µm cryosections was performed as described (Hartwig et al. 2010). The primary 
antibodies used were as follow: rabbit anti-Wt1 (C-19, Santa Cruz Biotechnology, Santa 
Cruz, CA), mouse anti-E-Cadherin (610181, BD Bioscience, San Jose, CA), goat 
anti-nephrin (N-20, Santa Cruz), rat anti-β1 integrin (MAB1997, Chemicon, Temecula, 
CA), rabbit anti-podocin (P0372, Sigma, St. Louis, MO), rabbit anti-NG2 chondroitin 
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sulfate (AB5320, Millipore, Billerica, MA), rabbit anti-PDGFRb (3169, Cell Signaling, 
Danvers, MA), rat anti- nidogen (MAB 1883, Chemicon), rat anti-PECAM1 (553370, 
BD Biosciences), and mouse anti-desmin (M0760, Dako, Carpinteria, CA). 
Fluorescence was detected using secondary antibodies conjugated to Texas Red and 
fluorescein isothiocyanate ﬂuorochromes (Jackson ImmunoResearch, West Grove, PA). 
RNA in situ hybridization was performed on embryonic and postnatal frozen kidney 
sections at a thickness of 8 µm using antisense probes. Corresponding sense negative 
controls did not produce background hybridization signals. SoxC probes were generated 
by PCR ampliﬁcation using the following primers: Sox4 forward, 
5’GAACGCCTTTATGGTGTGGT3’; Sox4 reverse, 
5’GGTAGACGCGCTTCACTTTC3’; Sox11 forward, 
5’GAGCCTGTACGACGAAGTGC3’; Sox11 reverse, 
5’TCAAAGAGCCACAAGCTTCA3’; Sox12 forward, 
5’AGAGCGGGTTCTCTTTAGGC3’; Sox12 reverse, 
5’TCAGCATGGGACAACACATT3’. PCR products were cloned into the pCRII- 
TOPO vector (Invitrogen, Carlsbad, CA). 
 
2.3.2 Glomerular Quantification 
Glomeruli were counted as described using the acid maceration method (MacKay et al. 
1987, Godley et al. 1996, Hoy et al. 2011). Brieﬂy, the left kidney of each animal was 
decapsulated (Sox4nephron-  n=4, wild-type n=4), cut into 2 mm3 pieces and incubated in 
5 mL of 6 N HCL at 37°C for 90 min, and tissue fragments were gently disrupted by 
aspirating up and down using a 10 mL pipette. The suspension was diluted to a total 
volume of 30 mL with water and incubated at 4°C overnight with rotation. The 
41 
 
preparation was resuspended and a 500 mL aliquot removed to a counting chamber. 
Glomerular number was counted under phase microscopy in triplicate. The number of 
glomeruli per kidney was determined by correcting the mean of the glomerular counts 
for dilution. 
 
2.3.3 Reverse Transcription Quantitative PCR (RT-qPCR) 
For embryonic stages, mouse embryos were excised from pregnant CD1 mice. Total 
RNA was isolated from 3 separate pooled biological samples from 9 to 10 pairs of 
kidneys at E11.5, E12.5, 5 to 6 pairs of kidneys at E14.5, and 2 to 3 pairs of kidneys at 
E16.5 A single kidney was collected at E18.5, P7 and P21 from 3 separate animals. 
Freshly harvested mouse kidneys were stabilized in RNA Later (Ambion, Austin, TX) at  
4°C overnight with rotation and then stored at -80°C according to manufacturer’s 
instructions. Tissues were homogenized using a Tissue-Tearor (Biospeciﬁcs Products, 
Lynbrook, NY) and total RNA was extracted using the RNAqueous 4-PCR kit 
(Ambion). RNA was reverse-transcribed using the Superscript III First-Strand cDNA 
Synthesis System (Invitrogen). For quantiﬁcation of SoxC mRNA levels, real-time PCR 
was performed using PerfeCTa SYBR Green Master Mix (Quanta Biosciences, 
Gaithers-burg, MD) and the Rotor-Gene 3000 detection system (Qiagen, Valencia, 
CA). The following SoxC primer sequences were used: Sox4 forward, 
5’GATCTCCAAGCGGCTAGGCAAA3’; Sox4 reverse, 
5’GTAGTCAGCCATGTGCTTGAGG3’; Sox11 forward, 
5’GGACCTGGATTCCTTCAGTGAG3’; Sox11 reverse, 
5’GTGAACACCAGGTCGGAGAAGT3’; Sox12 forward, 
5’CATTTCGAATTCCCGGACTA3’; Sox12 reverse, 
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5’GGTCGGCGATACTAGACGAG 3’. 
 
For absolute copy number determination, standard plots were constructed from known 
concentrations of serially diluted full-length SoxC cDNA plasmids (TrueORF Gold 
cDNA in pCMV6-Entry, OriGene Technolo2gies, Rockville, MD) over the 
concentration range of 101-107 copies/mL, as previously described (Pfaffl and Jolla 
2004, Dhanasekaran et al. 2010). Each standard dilution point was performed in 
triplicate over the complete standard-curve range to achieve a reliable standard curve for 
each measured parameter (R2 > 0.99; Efﬁciency (E) ≥ 1.95). Standard curves were 
performed for both target and plasmid cDNA in 3 or more replicates on different days to 
validate reproducibility (in all cases, R2> 0.99, E ≥ 1.95). qPCR experiments and 
analyses were performed with consideration for the Minimum Information for 
Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines (Bustin et 
al. 2010). Appendix C contains a table outlining relevant MIQE technical information. 
 
2.3.4 Mouse Strains 
The Sox4 null (Sox4-) allele (Schilham et al. 1996), conditional Sox4 (Sox4fx) allele 
(Penzo-Méndez et al. 2007) and Six2-Cre BAC transgenic line (Kobayashi et al. 2008) 
have been previously characterized. All animal experiments were carried out in 
accordance with the policies of the Animal Care Committee at the Atlantic Veterinary 
College, University of Prince Edward Island. 
 
2.3.5 Transmission Electron Microscopy 
Kidneys were cut into 3–4 mm thick sections, immediately immersed in 2% 
glutaraldehyde (SP1 Supplies, West Chester, PA) in 0.1 M phosphate buffer, pH 7.2, 
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and refrigerated for 30 min at 4°C. The cortical region was trimmed from each section 
and cut into smaller pieces and stored in 2% glutaraldehyde in phosphate buffer at 4°C 
overnight. Tissues were washed twice with phosphate buffer, post-ﬁxed in 1% osmium 
tetroxide (SP1 Supplies) in phosphate buffer pH 7.2, for 1 hr at room temperature, then 
washed for 10 min in 0.1 M phosphate buffer. Tissue was dehydrated through a graded 
series of ethanols, cleared in propylene oxide (SP1 Supplies), inﬁltrated and embedded 
in Epon (SP1 Supplies). Semi-thin sections (0.5 mm) were cut and stained with 1% 
toluidine blue in 1% sodium tetraborate solution and examined with a light microscope. 
All samples that contained at least two glomeruli were re-cut to generate ultrathin 
sections (90 nm). Ultrathin sections were stained with uranyl acetate and Sato’s lead 
stain. Sections were examined using a Hitachi H7500 transmission electron microscope 
operated at 80 kV and digital images were captured using an AMT XR40 side-mounted 
camera. 
 
2.3.6 Statistical Methods 
Two sample t-tests were performed using Minitab 16. Data are presented as mean ± 
standard error. 
 
 
2.4 Results and Discussion   
2.4.1 Dynamic Distribution of SoxC Transcripts During Renal Development 
Quantitative real-time qPCR and RNA in situ hybridization was performed to analyze 
the expression of SoxC transcripts at multiple stages of embryonic renal development, 
from the onset of renal development at E11.5 until E18.5, as well as at two post-natal 
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time-points, namely, P7 when nephrogenesis is completed, and in adult P21 kidneys 
(Figure 2.1).  Absolute quantitative qPCR (normalized to 25 ng RNA) shows that the 
three SoxC transcripts are highly expressed throughout renal development and in all 
cases are expressed at the lowest level in the adult (Figure 2.1A–C). Reference genes 
evaluated for qPCR using all three biological replicates for each time point were Gapdh, 
Pgk1 and Hprt1. Pgk1 was determined to be the most stable reference gene using both 
the NormFinder (Andersen et al. 2004) and BestKeeper (Pfaffl et al. 2004) algorithms. 
Trends of SoxC absolute copy number expression are maintained when normalized to 
Pgk1 (Appendix A). Preliminary evaluation of post-natal time points from P0 to P14 
shows that relative expression of Sox4 remains high from P0 to P9 before being reduced 
to the lowest level of expression in the adult (Appendix B). Further post-natal data will 
be needed to confirm this observation. 
 
Similar to previous reports of overlapping SoxC expression in developing tissues (Dy et 
al. 2008), SoxC transcripts exhibit an overlapping but distinct pattern of expression in 
the early developing kidney: Sox4, Sox11, and Sox12 are all expressed in nephron 
progenitors and in the ureteric bud (Figure 2.1D–F). Notably, strong Sox11 expression is 
also detected in epithelialized nephrogenic structures at E12.5. As development 
proceeds, strong Sox4 and Sox12 expression continues to be detected in nephron 
progenitors and ureteric bud lineages as well as in differentiating nephrogenic 
structures, as shown at E18.5 (Figure 2.1G,G’,I,I’). Similarly, Sox11 expression 
continues to be strongly detected in differentiating nephrogenic structures throughout 
renal development, including pretubular aggregates, comma-shaped and S-shaped  
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Figure 2.1. Expression of SoxC transcripts in the developing mouse kidney. A–C: 
Absolute copy number of SoxC transcripts (normalized to 25 ng total RNA) during renal 
development was detected by reverse transcription quantitative PCR (RT-qPCR) with 
specific primers recognizing Sox4, Sox11, and Sox12, using calibration curves from 
serially diluted recombinant SoxC plasmid DNA (n = 3 biological replicates). RNA 
from embryonic kidneys was dissected at E11.5, E12.5, E14.5, E16.5, E18.5, as well as 
at P7 and P21. Data are Mean + SE.  D–F: Sox4 and Sox12 are strongly expressed in 
nephron progenitors and in the ureteric bud lineages during early renal development as 
shown at E12.5, while Sox11 is preferentially expressed in pretubular aggregates. G–I, 
G’–I’: Sox4 and Sox12 continue to be expressed in nephron progenitors and ureteric bud 
during late renal development (E18.5), as well as in epithelialized nephrogenic 
structures together with Sox11 (arrowheads). Dashed red - outline of ureteric bud. Scale 
bar = 100 µm. 
 
 
bodies, with weak expression in nephron progenitors and ureteric bud (Figure 2.1H,H’).  
46 
 
Nephrogenesis is complete within the ﬁrst week of postnatal life, coincident with the 
absence of expression of nephron progenitor markers including Six2, Cited1, Meox1, 
and Dpf3 (Mugford et al. 2009, Brown et al. 2011). At this stage, diffuse Sox4 and 
Sox12 expression are detected in multiple cell types of the kidney, and low levels of 
Sox11 are also detected. Focal SoxC expression is observed in epithelialized tubules 
primarily in the renal papilla, and declines to low levels by P21 (data not shown). 
Consistent with the established roles for Sox4 and Sox11 during embryonic 
development, these expression data suggest a primary role for SoxC genes in directing 
different stages of nephrogenesis during renal development in vivo.  
 
SoxC proteins share a high degree of identity in their high-mobility group domain, and 
in the SoxC-speciﬁc transactivation domain. Of the three SoxC genes, Sox12 is the 
weakest transactivator in vitro (Dy et al. 2008). Sox12-/- mice develop normally, are 
fertile, and do not exhibit any obvious defects (Hoser et al. 2008). Genetic analyses of 
embryos with all combinations of SoxC -null alleles reveals that loss of Sox12 only 
slightly aggravates the phenotype of Sox4+/-;Sox11+/- and Sox4-/-; Sox11-/- embryos 
(Bhattaram et al. 2010). Collectively, these genetic studies demonstrate that Sox12 is 
dispensable, providing only minor contributions during embryonic development in vivo, 
possibly due to low transcriptional competence of its protein product.  
 
In contrast, independent, essential roles for Sox4 and Sox11 have been demonstrated in 
heart development in vivo. Sox4-/- mice die prior to E14 due to cardiac outﬂow tract 
malformation, exhibiting a primary failure of the endocardial ridge differentiation into 
semilunar valves (Schilham et al. 1996). Sox4 is also required for differentiation of T 
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and B lymphocytes (Schilham et al. 1996, 1997), pancreatic β-cells (Wilson et al. 2005) 
and osteoblasts (Nissen-Meyer et al. 2007). Sox11-/- mice die shortly after birth, with 
similar but less severe heart malformations than Sox4-/- embryos, and exhibit other 
defects in organogenesis (Sock et al. 2004). Analyses of compound Sox4-/- and Sox11-/- 
embryos demonstrate that Sox4 and Sox11 act partially redundantly to control key neural 
and mesenchymal progenitor cell fate decisions during organogenesis in vivo 
(Bhattaram et al. 2010, Thein et al. 2010, Bergsland et al. 2011, Shim et al. 2012). 
Compound Sox4-/-;Sox11-/- kidneys have not been studied in vivo, due to early 
embryonic lethality (E8.5) of compound Sox4-/-;Sox11-/- embryos. Notably, Sox4-/-; 
Sox11+/- embryos exhibit more severe phenotypic abnormalities than Sox4+/-; Sox11-/- 
embryos in early organogenesis, and are almost as severely affected as Sox4-/-; Sox11-/- 
embryos. These genetic data suggest that in tissues co-expressing both Sox4 and Sox11, 
Sox4 may play a greater role in early developmental processes, while Sox11 may 
function more strongly in later stages of development. These observations are consistent 
with the distinct expression pattern of Sox4 in early nephrogenic structures and Sox11 in 
more mature nephrogenic structures, collectively suggesting that Sox4 and Sox11 may 
function nonredundantly to control early and late aspects of nephrogenesis, respectively, 
in vivo.  
 
2.4.2 Sox4 Mutant Mice Develop Postnatal Renal Disease  
To begin this investigation of SoxC function during nephrogenesis, Sox4 function was 
ablated in nephron progenitors and their cellular descendents (Sox4nephron- mice) using a 
well-characterized Six2Cre (Six2TGC) transgenic mouse strain (Kobayashi et al. 2008, 
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Ho et al. 2011). Analysis of Sox4nephron- embryonic kidneys did not reveal any overt 
abnormalities; Sox4nephron- mutant newborns appeared normal, and were born at the 
expected Mendelian ratios.  
 
However, Sox4nephron- glomeruli appeared hypocellular at P7 (Figure 2.2A vs. B; Figure 
2.3A vs. B), and nephron number was signiﬁcantly (48%) reduced in Sox4 nephron- 
kidneys compared to wild-type controls by acid maceration (Figure 2.2C; P < 0.006; 
n=4). Within 2 weeks of birth, Sox4nephron- mice appeared smaller than wild-type 
littermates, and reductions in weight became signiﬁcant within 5 weeks (11.7±0.52%, P 
< 0.05, wild-type n=5; Sox4 mutant N=9).  
 
By P16, Sox4nephron- mutant kidneys had undergone a remarkable alteration, exhibiting a 
poorly organized renal medulla and cortex, and numerous dilated tubules containing 
periodic acid–Schiff (PAS)+ protein casts (Figure 2.3B,D, vs. A,C). Abundant PAS+ 
protein reabsorption granules were observed in the cytoplasm of proximal tubules of 
Sox4nephron- mutant kidneys (Figure 2.3D,D’ vs. C,C’), evidencing substantial proximal 
tubular reabsorption of abnormally high levels of protein and lipoproteins in the urine, a 
hallmark of nephrotic range proteinuria and glomerular disease (Laurinavicius et al. 
1999, Schwimmer et al. 2003). Renal corpuscles in Sox4nephron- mutants were markedly 
hypocellular compared to wild-type littermates and had poorly-deﬁned glomerular 
tufts (Figure 2.3B’vs. A’). Characteristically thin PAS+ basement membrane staining of 
the glomerular capillary loops and tubular epithelium in wild-type animals is lost in 
Sox4 mutants (Figure 2.3D’vs.C’), indicating damage to glomerular capillary loops, 
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Figure 2.2. Reduced nephron endowment in Sox4nephron- kidneys. A,B: P7 renal 
histology. The number of glomeruli (arrows) was greater in control (A) versus 
Sox4nephron- mice (B). C: Glomerular number is significantly reduced in Sox4nephron- mice 
(48%) compared to wild-type littermates (*P < 0.006; n=4). Data are mean ± SE. 
 
 
together with increased mesangial matrix in these animals. Collectively, these ﬁndings 
are consistent with early-onset proteinuria and glomerular disease in Sox4 mutant 
animals. 
 
Sox4nephron- mutants progress to end-stage renal disease between 5–9 months of age. 
Histologic analysis of Sox4nephron- mutant kidneys at 5 months revealed an abundance of 
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grossly dilated tubules containing protein casts as compared to wild-type controls 
(Figure 2.4B,D vs. A,C). Glomeruli of Sox4nephron- mutants lack clear vascular tufts, and 
exhibit widespread sclerosis with reduced urinary space between the parietal and 
visceral epithelial layers of Bowman’s capsule (Figure 2.4B’ vs. A’). PAS staining 
showed a thickening of capillary basement membranes and marked mesangial matrix 
accumulation in Sox4nephron- mutant glomeruli, together with focal loss of proximal 
tubular brush border indicative of proximal tubule injury (Figure 2.4D’ vs. C’). Renal 
pathology was also observed by electron microscopy in these same Sox4nephron- mutant 
mice. 
 
Assessment of wild-type kidneys revealed glomeruli with a normal, uniform glomerular 
basement membrane (GBM), and regular, interdigitating podocyte foot processes 
(Figure 2.5A,A’). In contrast, Sox4nephron- mutant glomeruli display extensive podocyte 
foot process effacement and apparent fusion characteristic of proteinuric glomerular 
disease (Figure 2.5B vs. A). The GBM in these mice is markedly thickened and 
numerous subepithelial aggregates of electron-dense deposits are present (Figure 
2.5C,C’), a hallmark of membranous nephropathy (Pavelka and Roth 2005). Together, 
histological and ultrastructural assessment demonstrate that the structure and function of 
the glomerular ﬁltration barrier is abrogated in Sox4nephron-mutant mice. 
 
The observation of reduced nephron endowment in Sox4nephron- mice demonstrates an 
essential role for Sox4 in nephrogenesis in vivo. However, the severity of the early-onset 
proteinuric glomerular injury observed in postnatal Sox4nephron- mice is not easily 
explained by a reduction in nephron number, and suggests a requirement for Sox4 in 
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Figure 2.3. Early post-natal renal phenotype of Sox4nephron- mice. A,A’,B,B’: H&E stain 
of the renal cortex. At P16, Sox4nephron- kidneys are characterized by tubular dilatation 
(*), poorly defined glomerular tufts, and reduced cellularity of the renal corpuscle 
(arrowheads) compared to wild-type littermates (B,B’ vs. A,A’). Boxes denote regions 
shown in high magnification. C,C’, D,D’: PAS stain of renal cortex and medulla. 
Sox4nephron- kidneys exhibit numerous dilated tubules containing PAS+ protein casts 
(black arrows), and proximal tubules contain abundant protein reabsorption granules 
(red arrows) characteristic of nephrotic range proteinuria (D vs. C). Sox4nephron- 
glomeruli exhibit diffuse thickening of the glomerular capillary basement membrane 
and increased mesangial matrix compared to wild-type littermates (D’ vs. C’). v, renal 
vein. Scale bar = 100 µm. 
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podocyte development and/or adult podocyte maintenance. Given the complex and 
poorly-understood interplay between podocytes, endothelium, mesangium, and 
glomerular basement membrane, it is possible that alterations in podocyte gene 
expression or morphology could cause secondary responses in these cell types, which 
would further exacerbate glomerular injury. Indirect immunoﬂuorescence for key 
glomerular markers in Sox4nephron- kidneys at E17.5 and in P7 kidneys (Figure 2.6) was 
performed in order to assess whether Sox4 may regulate glomerular development and/or 
maintenance. At E17.5, Sox4nephron- glomeruli did not exhibit alterations in expression of 
early glomerular markers including glomerular basement proteins nidogen (Figure 2.6A 
vs. B) and β1 integrin (data not shown), glomerular mesangial markers including 
neural/glial antigen 2 (NG2) chondroitan sulfate (Figure 2.6E vs. F), desmin, and 
platelet-derived growth factor receptor (data not shown), endothelial protein platelet and 
endothelial cell adhesion molecule 1 (PECAM-1) (Figure 2.6I vs. J), podocyte slit 
diaphragm proteins nephrin (Figure 2.6M vs. N) and podocin (Figure 2.6Q vs. R), or in 
the podocyte nuclear marker Wt1 (Figure 2.6U vs. V). However, by P7, Sox4nephron- 
glomeruli exhibited a speciﬁc reduction in nephrin expression, as evaluated by 
immunofluorescence (Figure 2.6 O vs. P) while expression of podocin as well as other 
markers of the endothelium, mesangium, and basement membrane continued to be 
normally expressed. Nephrin is a large transmembrane protein of the immunoglobulin 
(Ig) superfamily, and a key structural component of the podocyte slit diaphragm 
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Figure 2.4. Adult (5 months) renal phenotype of Sox4nephron- mice. A–D: H&E and PAS 
staining of the renal cortex demonstrate the presence of numerous, large tubular 
dilatations (*) and protein casts (arrows) in Sox4nephron- mice compared to wild-type 
littermates (B,D vs. A,C). A’–D’: Higher magnification of boxed areas. 
Sox4nephron-glomeruli (arrowheads) exhibit hypocellularity and capillary loss (B’ vs. A’), 
as well as reduction of the urinary space between the parietal and visceral epithelia in 
Bowman’s capsule (B’,D’; vs. A’,C’). Sox4nephron- glomeruli exhibit markedly thicker 
basement membranes and abundant PAS+ mesangial matrix compared to wild-type 
littermates, as well as distal tubule dilatation and loss of proximal tubular brush border 
(D’ vs. C’).  v, renal vein. Scale bar = 100 µm. 
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Figure 2.5. Ultrastructure of glomerular damage in adult (5 months) Sox4nephron- kidneys. 
A,A’,B,B’: Sox4nephron- glomeruli exhibit extensive podocyte injury characterized by foot 
process effacement (black arrow-heads) and morphologic irregularity. The glomerular 
basement membrane (GBM) is markedly thickened (star) in Sox4nephron- mice (B,B’ vs. 
A,A’). C,C’: Numerous large aggregates of subepithelial electron-dense material are 
present in the GBM (white arrowheads) of Sox4nephron- glomeruli. Boxes denote regions 
shown in high magnification in bottom panels. Scale bar = 500nm. 
 
 
(Tryggvason et al. 2006). The regular spacing between adjacent podocyte foot processes 
is maintained through adhesive interactions between nephrin and other Ig superfamily 
proteins expressed on opposing foot processes. Loss or abnormal function of nephrin 
leads to proteinuria due to loss of the slit diaphragm and foot process effacement (Jones 
et al. 2009, New et al. 2013). Results from this study demonstrate reduced nephrin 
expression in P7 Sox4nephron- glomeruli, suggesting that loss of nephrin expression may 
partly underlie the observed glomerular phenotype observed in P16 Sox4nephron- mice.  
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Figure 2.6. Expression of endothelial, mesangial, podocyte, and GBM components in 
Sox4nephron- versus control littermates at E17.5 and P7. Expression of (A–D) basement 
membrane protein nidogen, (E–H) mesangial marker NG2, and (I–L) endothelial protein 
PECAM-1 was not altered in Sox4nephron- kidneys. M–P: Expression of the slit diaphragm 
protein nephrin is reduced in P7 Sox4nephron- glomeruli, while (Q–T) podocin expression 
is unchanged compared to wild-type controls. U–X: Expression of the podocyte nuclear 
marker WT1 is reduced in P7 Sox4nephron- kidneys. Representative images are shown 
from at least 15 glomeruli examined per kidney (n=3). 
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The number of WT1+ podocyte nuclei is also reduced in Sox4nephron- kidneys at P7 as 
evaluated by immunofluorescence (Figure 2.6X vs. W). Nephrin is a transcriptional 
WT1 target (Wagner et al. 2004). Alternatively, loss of nephrin expression in Sox4nephron- 
kidneys may be secondary to reduced WT1 expression in Sox4nephron- podocytes, 
suggesting a role for Sox4 in regulation of WT1 in podocytes. Importantly, reduced 
numbers of WT1+ podocytes in Sox4nephron- renal corpuscles may reﬂect reduced 
podocyte numbers in these mice, suggesting that aberrant nephrin expression and 
glomerular injury may be partly attributable to podocyte loss in Sox4nephron- kidneys, 
supporting a role for Sox4 in podocyte development in vivo. 
 
In summary, this study has deﬁned the relative abundance and subcellular distribution of 
the three SoxC genes during renal development. Postnatal analysis of Sox4 mutant mice 
demonstrates an essential requirement for at least one member of the SoxC sub-family in 
nephrogenesis in vivo, and suggests potential roles for Sox4 in podocyte development 
and/or adult podocyte maintenance. Future studies will assess whether Sox4 
transcriptionally regulates nephrin expression in vitro. Conditional gene deletion studies 
will be aimed at ablating Sox4 in podocytes to determine the speciﬁc role of Sox4 in the 
podocyte lineage, and to evaluate the independent role of Sox11 as well as the combined 
role of Sox4/Sox11 signalling during renal development in vivo. 
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3. Estimation of total glomerular number using an integrated disector method in 
embryonic and postnatal kidneys 
 
A version of this chapter has been published: 
 
Arsenault, M. G., Miao, Y., Jones, K., Sims, D., Spears, J., Wright, G. M., and Hartwig, 
S. 2014. Estimation of total glomerular number using an integrated disector method in 
embryonic and postnatal kidneys. Canadian Journal of Kidney Health and Disease 1:12 
 
3.1 Abstract 
Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) are a polymorphic 
group of clinical disorders comprising the major cause of renal failure in children. 
Included within CAKUT is a wide spectrum of developmental malformations ranging 
from renal agenesis, renal hypoplasia and renal dysplasia (maldifferentiation of renal 
tissue), each characterized by varying deficits in nephron number. First presented in the 
Brenner Hypothesis, low congenital nephron endowment is becoming recognized as an 
antecedent cause of adult-onset hypertension, a leading cause of coronary heart disease, 
stroke, and renal failure in North America. Genetic mouse models of impaired 
nephrogenesis and nephron endowment provide a critical framework for understanding 
the origins of human kidney disease. Current methods to quantitate nephron number 
include (i) acid maceration (ii) estimation of nephron number from a small number of 
tissue sections (iii) imaging modalities such as MRI and (iv) the gold standard physical 
disector/fractionator method. Despite its accuracy, the physical disector/fractionator 
method is rarely employed because it is labour-intensive, time-consuming and costly to 
perform. Consequently, less rigorous methods of nephron estimation are routinely 
employed by many laboratories. In the current study an updated, digitized version of the 
physical disector/fractionator method (using free open source Fiji software), termed the 
integrated disector method is presented. This updated version of the gold standard 
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modality accurately, rapidly and cost-effectively quantitates nephron number in 
embryonic and post-natal mouse kidneys, and can be easily adapted for stereological 
measurements in other organ systems.  
 
3.2 Introduction 
Defects in nephrogenesis and ureteric branching result in CAKUT. With an incidence of 
1:400 (Nakanishi and Yoshikawa 2003), CAKUT constitute one of the most frequent 
birth defects in humans, and the major cause of childhood renal failure (Pope et al. 
1999, Seikaly et al. 2003). These pleiotropic malformations comprise a multitude of 
renal phenotypes including renal agenesis, hypoplasia and renal dysplasia, associated 
with obstructive or refluxive anomalies of the ureter (Weber 2012). CAKUT are 
predicted to have different genetic origins (Nakanishi and Yoshikawa 2003), yet the 
molecular pathogenesis of CAKUT is not well understood. Nephron deficiency is a 
hallmark feature of CAKUT. In fact, nephron number varies greatly even within the 
normal distribution, ranging from 7,000 to 20,000 in mice (Cebrian et al. 2004, 
Murawski et al. 2010, Zhong et al. 2012), and from 200,000 to 2 million in humans 
(Hughson et al. 2003, Hoppe et al. 2007, Bertram et al. 2011). Low nephron endowment 
within this normal range - though asymptomatic early in life, is associated with 
adult-onset hypertension (Keller et al. 2003, Reyes and Mañalich 2005, Walker et al. 
2012), a disease affecting 73 million North Americans and a leading cause of coronary 
heart disease, stroke, and renal failure in North America (Wilkins et al. 2010, Tedla et 
al. 2011). Despite the fundamental importance of nephron endowment to human health 
and disease, only a minority of molecular mechanisms underlying nephron 
morphogenesis have been identified. To this end, mouse models of impaired 
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nephrogenesis and nephron endowment provide an important framework for 
understanding the molecular and developmental origins of human kidney disease. 
 
Four main methods are currently employed to quantitate glomerular number (Nglom) in 
the kidney (Bertram 2013). The most accessible methods for estimating glomerular 
number by virtue of their ease of performance, relative low cost and rapidity, are (i) acid 
maceration and (ii) quantitation of glomeruli in a small number of histological sections. 
In the acid maceration method, the kidney is decapsulated, cut into small pieces and 
incubated in a weakly acidic solution. Tissue fragments are gently disrupted by manual 
aspiration which dissociates glomeruli in the suspension, and Nglom is counted within a 
known volume in a chamber similar to a hemocytometer (MacKay et al. 1987, Godley et 
al. 1996). Acid maceration is a rapid, simple and inexpensive means of obtaining Nglom; 
however, this method is subject to some of the same sources of counting errors and 
consequent low precision associated with hemocytometer use, including non-uniform 
suspensions and non-adherence to convention for counting glomeruli in contact with 
boundary lines or each other. A tacit assumption in the acid maceration method is that 
glomerular structural integrity is equivalent between sample groups. While not 
previously reported in the literature, it is feasible that disease states or genetic mutations 
that deleteriously affect the structural integrity of the glomerulus would render 
glomeruli more susceptible to acid digestion. Under such conditions, spurious 
differences in glomerular number could be obtained due to degradation of glomeruli in 
suspension, rather than true differences in glomerular number between groups. 
 
A second commonly employed method involves evaluation of stained histological 
66 
 
sections of the kidney. A small number of kidney tissue sections are chosen and 
glomerular number is counted and reported per area of tissue, or cortex. Although 
straightforward to perform, it is a biased sampling method that does not provide an 
accurate depiction of glomerular number for the entire kidney. Using this method, a 
glomerulus that is longer perpendicular to the plane of sectioning has a higher 
probability of being sampled in any given section than would the same glomerulus 
orientated parallel to the plane of sectioning. The number of glomeruli counted using 
this method not only depends on glomerular number and density, but also on their size 
and shape, which are not equally distributed throughout the kidney (Samuel et al. 2005, 
Kanzaki et al. 2013). 
 
The use of micro-magnetic resonance imaging (MRI), also known as high-field MRI, is 
a third modality that can provide quantitative measurements in vivo and therefore holds 
great potential for future human applications. MRI provides both rapid and accurate 
evaluation of total glomerular number in healthy kidneys (Beeman et al. 2011, 
Heilmann et al. 2012). However, access to micro-MRI systems is costly, rendering it 
less accessible to many laboratories. In addition, the accuracy of MRI is significantly 
reduced in kidneys with focal and segmental glomerulosclerosis (Bennett et al. 2008), 
due to the low retention of the MRI contrasting agent, cationic ferritin, in the basement 
membranes of diseased glomeruli. Thus, disease states or genetic mutations that affect 
the integrity of the glomerular basement membrane may alter the retention of the 
contrasting agents in affected glomeruli, and can spuriously skew results. 
 
The gold standard method for estimating Nglom is the unbiased physical 
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disector/fractionator method. This stereological method involves exhaustively 
sectioning the kidney, and using a physical disector (a stereological probe) to count 
glomeruli in pairs of tissue sections. The application of stereology in biological systems 
and in the context of the kidney has been well-described (Howard and Reed 1998, 
Nyengaard 1999). Briefly, this approach uses a pair of projection microscopes, a pencil 
and paper to manually circle and count glomeruli (Cullen-McEwen et al. 2012b). The 
physical disector method is extremely accurate because it is unbiased, but is very 
labour-intensive to perform, requiring a full day for an experienced technician to 
complete quantitation of a single rat kidney (Bertram 2013). Commercially-available 
software packages offer powerful stereological alternatives to using projection 
microscopes for the physical disector/fractionator method (Cullen-McEwen et al. 
2012b), but are cost-prohibitive to most laboratories. It is also interesting to note that 
although the mathematics and theory of unbiased stereology have come a long way in 
the past several decades, the actual technical methods for sampling the number of 
glomeruli presented by Cullen-McEwan et al. (2012b) somewhat resemble those used 
by Miller and Carleton in 1894 with the use of a camera lucida in place of projection 
microscopes (Miller 1894) 
 
Members of the Sry-Related HMG Box (Sox) gene family have been shown to play 
master regulatory roles in a multitude of developmental processes including 
dorso-ventral patterning (Chen et al. 2012), stemness (Avilion et al. 2003, Masui et al. 
2007, Wang et al. 2012), male differentiation (Koopman et al. 1991, Wagner et al. 
1994), neurogenesis (Bhattaram et al. 2010, Bergsland et al. 2011, Mu et al. 2012), 
cardiac outflow tract, B-lymphocyte (Schilham et al. 1996) and spinal cord development 
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(Shim et al. 2012), and skeletogenesis (Akiyama and Lefebvre 2011, Lefebvre and 
Bhattaram 2016). Recently Sox4 has been identified as a critical regulator of normal 
renal development in vivo (Huang et al. 2013). Using an established Six2-Cre transgenic 
mouse line (Kobayashi et al. 2005, 2008), Sox4 function was ablated in nephron 
progenitors and their cellular descendants (Sox4nephron- mice). Using the acid 
maceration method, it was demonstrated that Sox4nephron- kidneys exhibit 48% 
reduction in nephron number compared to wild-type animals. In light of the low 
precision associated with this method and the inherent limitations associated with each 
of the existing methods of glomerular quantitation, I sought to develop an accurate, 
rapid and cost-effective alternative means of quantitating nephron number that could be 
of use to the nephrology community. 
 
ImageJ is an open source image processing program through the US National Institutes 
of Health which has been freely available for more than 15 years (Schneider et al. 2012). 
Fiji is a free biological imaging package within ImageJ that comes pre-loaded with the 
TrakEM2 plugin for morphological data mining and three-dimensional modeling, and 
includes a stereological disector tool (Cardona et al. 2012, Schindelin et al. 2012). By 
integrating the stereologic principles of the physical disector/fractionator method with 
automated light microscopy and ImageJ/Fiji software, I have developed an accurate, 
rapid, cost-effective method for quantitation of total nephron number in embryonic day 
(E)17.5 murine kidneys (including S-shaped bodies and maturing glomeruli), and 
estimation of nephron number in postnatal day (P)7 murine kidneys. Thus, I present the 
integrated disector method as a highly accessible updated version of the physical 
disector/fractionator method that can be easily adopted for in house application with 
69 
 
minimal set up costs. 
 
3.3 Materials and Methods 
3.3.1 Mouse Strains 
The Sox4 null (Sox4-) allele (Schilham et al. 1996), conditional Sox4 (Sox4fx) allele 
(Penzo-Méndez et al. 2007) and Six2-Cre BAC transgenic line (Kobayashi et al. 2008) 
have been previously characterized. All animal experiments were carried out in 
accordance with the policies of the Animal Care Committee at the University of Prince 
Edward Island and according to the Canadian Council on Animal Care guidelines.  
 
3.3.2 Histochemical Staining 
Kidneys were isolated from E17.5 (n=4 Six2Cre;Sox4fx/- (Sox4nephron-); n=4 wild-type)  
and P7 (n=4 Sox4nephron-; n=3 wild-type) mice. Kidneys were fixed in 10% neutral 
buffered formalin (Sigma-Aldrich, St. Louis, MO), processed to paraffin blocks and 
exhaustively sectioned in the sagittal plane at 5µm. Ribbons of serial E17.5 sections 
were mounted on glass slides, such that every section of the kidney was captured on a 
set of slides. Sections were stained with biotinylated peanut agglutinin (PNA) as 
described previously (Cullen-McEwen et al. 2012a) with the following modifications: 
reduced incubation time of the biotinylated PNA to 10 minutes and without hematoxylin 
counterstaining. Paired sections from P7 kidneys were selected using a systematic 
uniform random sampling approach as described (Cullen-McEwen et al. 2012b). 
Post-natal sections were stained with periodic acid-Schiff (PAS). 
 
3.3.3 Fiji Processing of Kidney Section Images 
The established workflow for embryonic kidneys was as follows (Figure 3.1): Digital 
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images of each stained section were captured by automated light microscopy using an 
Olympus BX61 Virtual Slide Microscope with motorized stage. Images were imported, 
converted to 8-bit grey and resized using Fiji software (Schindelin et al. 2012). All of 
the images for a single embryonic kidney were then imported into a single stack and 
registered using the TrakEM2 plugin (Cardona et al. 2012). The disector tool within the 
TrakEM2 environment was then used to count every glomerulus within the kidney. 
Individual glomeruli were tagged with a unique ID which was maintained between 
sections, and reports were generated.  
 
 
Figure 3.1. Processing of kidney section images. Schematic of workflow for quantitation 
of glomerular number using the integrated disector/fractionator method.  
 
A similar approach was used to estimate glomerular number in postnatal kidneys. A 
pilot study was conducted to determine mean maximal glomerular size and the total 
number of sections through a P7 kidney, and the optimal section sampling fraction was 
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determined to estimate total glomerular number (please see Cullen-McEwan et al., 2012 
for detailed protocol). Paired sections were imported, converted to 8-bit colour and 
manually aligned. The disector tool was then used to identify glomeruli that were either 
present on both paired sections or on only one of the two. Those present on only one of 
the two sections were counted as disector particles and used to estimate the total number 
of glomeruli (for more detailed technical instructions please refer to APPENDIX D).  
 
3.3.4 Statistical Methods  
Two sample t-tests were performed using Minitab 16 to compare changes in nephron 
endowment between Sox4nephron- and wild-type mice. Data are presented as mean ± 
standard deviation. 
 
3.4 Results and Discussion 
3.4.1 Assessment of Glomerular Number in Sox4nephron- Kidneys 
Given the inherent limitations associated with existing methods of glomerular 
quantitation, I sought to develop an accurate, rapid and cost-effective alternative means 
of quantitating nephron number in the Sox4nephron- kidneys. As the physical 
disector/fractionator method provides the most accurate quantitative measurements of 
glomerular number in both healthy and diseased kidneys, ways to reduce the time and 
labour involved in this process, at low cost was sought. To this end, I opted for 
automated microscopy combined with free open source Fiji image analysis software to 
develop a highly accessible workflow that has been termed the integrated disector 
method. This workflow allows for the application of the physical disector/fractionator 
method in house and is a simple adaptation of the technical implementation of the 
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physical disector/fractionator method described in the literature. The integrated disector 
method is a straightforward, rapid, and accurate means of quantitating nephron number 
in both embryonic and postnatal kidneys. In E17.5 mouse kidneys, PNA-stained 
S-shaped bodies and glomeruli are efficiently identified and counted using the TrakEM2 
plugin and Fiji software. Quantitation of total glomerular number in E17.5 kidneys of 
Sox4nephron- (n=4) and wild-type (n=4) mice demonstrated a 36% reduction in glomerular 
number (p=0.001) in Sox4nephron- kidneys compared to wild-type littermates (Figure 3.2a). 
In P7 kidneys, glomeruli were identified using PAS staining. A disector was used to 
obtain accurate unbiased estimates of total glomerular number from pairs of sections 
using the TrakEM2 plugin and Fiji software. Estimation of total glomerular number in 
P7 kidneys of Sox4nephron- (n=4) and wild-type mice (n=3) demonstrated a 32% reduction 
in glomerular number in Sox4-deficient kidneys compared to wild-type (p=0.012) 
(Figure 3.2b). The integrated disector method obtained glomerular numbers similar to 
those reported in the literature for both embryonic and postnatal wild-type kidneys 
(Cebrian et al. 2004). 
 
Using acid maceration, it was previously reported that there was a substantially greater 
reduction (48%) in glomerular number in Sox4-deficient kidneys at P7 (Chapter 2). This 
difference is likely attributable to the high variability (low precision) inherent to the acid 
maceration technique. Variability in the acid maceration technique of glomerular 
quantitation is introduced by (i) pipetting errors (ii) non-uniform suspension of 
glomeruli and most significantly (iii) high standard deviation and its derivative 
coefficient of variability (CV) arising from the extrapolation of Nglom from a small 
volume (500 µL) to Nglom in the total volume (30 mL)(Shapiro 2003). Indeed, 
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quantitation of Nglom using acid maceration is associated with a high CV in both 
wild-type kidneys (12.7%) and in Sox4 mutant kidneys (15.6%), which may largely  
 
 
Figure 3.2. Reduced nephron endowment in Sox4nephron- (KO) kidneys. A) Total 
glomerular number is significantly reduced in Sox4nephron- kidneys (36%) compared to 
wild-type littermates (WT) at E17.5 (***p=0.001; wild-type n=4; Sox4nephron- n=4). B) 
Glomeruli number is significantly reduced in a Sox4nephron- kidneys (32%) compared to 
wild-type littermates at P7 (*p=0.012; wild-type n=3; Sox4neprhon- n=4). 
 
 
explain the difference in Nglom obtained using acid maceration vs. integrated disector 
methodologies. When restricted by cost and resources, acid maceration continues to 
provide useful insight into kidney development and physiology. This approach lends 
itself particularly well in instances where large between-group differences exist, as in 
the case of Sox4-mutant vs. wild-type glomerular number, and has recently been used 
for validation of new MRI approaches (Beeman et al. 2011). However, it is generally 
accepted and understood that stereology is a more robust approach for quantification of 
glomeruli. Indeed, the high variability inherent to the acid maceration technique was a 
significant motivation for us to implement cost-effective in house stereological methods 
for glomerular quantitation.  
A B 
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3.4.2 The Integrated Disector Method is Cost-Effective and Accessible 
Several open source biomedical image analysis software packages have recently become 
available including Endrov (Henriksson et al. 2013), Icy (Chaumont et al. 2012), 
BioImagXD (Kankaanpää et al. 2012) and Fiji (Schindelin et al. 2012). Each package 
has a specialized focus and toolset to facilitate processing of complex biological 
spatio-temporal image data obtained mainly by microscopy. While developing the 
approach presented here, multiple avenues were explored, each with their own 
advantages and disadvantages before we settled on the use of trakEM2 and Fiji/ImageJ, 
including the use of various software packages such as IMOD (Kremer et al. 1996), 
various machine-learning algorithms and approaches (Sommer and Gerlich 2013) and 
the use of other Image J plugins, including Trainable Weka Segmentation. Certainly, 
multiple strategies can be developed to perform glomerular quantitation with high 
accuracy, speed and economy. However, to the best of my knowledge, this is the first 
study to report a means of combining the high accuracy of the physical 
disector/fractionator gold standard method with the power and economy of open source 
image analysis software.  
 
Although many groups are studying the effects of genes and various environmental 
factors on the development and function of the kidney, there is currently no broadly 
accessible method for accurately determining if there is an effect on nephron 
endowment. In the present study, PNA and PAS staining of histological sections were 
optimized to identify glomeruli in embryonic and postnatal kidneys. The 
implementation of the physical disector/fractionator method has been updated by 
75 
 
combining semi-automated microscopy image capture with Fiji/TrakEM2 to streamline 
data collection and image analysis. With minimal setup costs, these tools can permit 
accurate, efficient and rapid stereological measurement of glomerular number in many 
laboratories, and can be applied from early embryonic development through to the adult 
mouse. Implementing the integrated disector requires laboratories to follow the same 
steps associated with the physical disector/fractionator method from tissue embedding to 
exhaustive sectioning and staining of tissue (Cullen-McEwen et al. 2012b). The power 
of this approach is in its ease of set up and accessibility for counting Nglom using a freely 
available disector tool which allows for unbiased estimation of Nglom. Total time for 
image acquisition and analysis for an experienced user and full automation would 
average 2-3 hours per kidney. Smaller laboratories that may not have access to 
motorized microscopes can easily outsource the image capture component to 
collaborators while performing the Fiji/TrakEM2 quantitation in-house. Alternatively, 
researchers can manually capture overlapping partial images of serial sections at the 
appropriate magnification, and sections can be stitched using the Grid/Collection 
stitching plugin built-in to Fiji. Stitched sections can then be loaded into the TrakEM2 
environment and analysed as described. Other refinements and adaptations can be 
performed to best suit the needs of individual research teams, including the acquisition 
of volumetric data, and can be broadly applied towards stereological measurements in 
other organ systems. 
 
In summary, the physical disector/fractionator method of stereological glomerular 
quantitation has been adapted using semi-automated microscopy together with open 
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source Fiji software and the TrakEM2 plugin. The integrated disector method is 
presented in the hopes of offering the general nephrology community an accurate, rapid, 
cost-effective and therefore highly-accessible means of glomerular quantification in 
embryonic and postnatal kidneys.  
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4. Sox4 in kidney development: an exploration of possible mechanisms through 
preliminary data 
 
4.1 Abstract 
The transcription factor Sry-Related HMG Box-4 (Sox4) has been shown to be essential 
for normal renal development in vivo. In Chapters 2 and 3, it was shown that conditional 
ablation of Sox4 in nephron progenitors and their cellular descendants (Sox4neprhon- mice) 
results in a significant reduction in nephron endowment. These mice also develop 
early-onset proteinaceous glomerular injury which progresses to end-stage renal failure 
within 5-9 months. In this study the reduced nephron endowment in Sox4neprhon- mice is 
shown to result from the formation of fewer pretubular aggregates, likely as a result of 
decreased cell cycling of nephron progenitor cells. Sox4 and Sox11 are also dispensable 
for normal podocyte differentiation and function. Conditional deletion of both of these 
genes individually as well as in combination in podocytes resulted in no apparent 
glomerular phenotype after 6 months and does not recapitulate the phenotype observed in 
Sox4neprhon- kidneys. Analysis of Sox4neprhon- kidneys suggests that the genesis of 
glomerular injury may be activated parietal epithelial cells (aPEC). Collectively, these 
results demonstrate that Sox4 plays multiple crucial roles in normal kidney development 
and function in vivo.  
 
4.2 Introduction 
Kidney development results from a complex series of reciprocal signaling events. As the 
ureteric bud (UB) invades the metanephric mesenchyme (MM) and reciprocal signaling 
ensues, the cells of the MM that are closest to the UB tips condense and form a distinct 
subdomain of the MM, often referred to as cap mesenchyme. These Six2+ cells 
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represent a nephron-committed, self-renewing progenitor population that is responsible 
for generating all the segments of the functioning nephron (Figure 4.1). Briefly, the 
committed cells begin to cluster into pretubular aggregates (PTA) which further 
differentiate and epithelialize to form the renal vesicle (RV). The epithelial RV then 
forms a lumen and unwinds to sequentially form comma-shaped and S-shaped bodies. 
The layers of Bowman’s capsule (BC) (parietal layer, Bowman’s space, visceral layer, 
filtration barrier) are generated from the proximal RV in conjunction with the attraction 
of angioblasts from the surrounding interstitium to the proximal RV to form the 
glomerular capillaries. The distal RV fuses with the UB tip and further proliferates and 
differentiates to form the various tubular segments of the functioning nephron (Little 
and McMahon 2012, McMahon 2016).  
 
The podocyte is a highly specialized epithelial cell that covers the glomerular 
capillaries, representing the visceral layer of Bowman’s capsule, and has been the focus 
of significant research in normal and pathological conditions for several decades 
(Shankland et al. 2014). A unique characteristic of the podocyte is the network of 
interdigitated foot processes with their slit diaphragms, that along with the glomerular 
basement membrane (GBM) and underlying fenestrated endothelium of the glomerular 
capillaries, make up the glomerular filtration barrier (Barisoni and Mundel 2003). The 
loss of integrity of the filtration barrier leads to proteinuria and disease (Menon et al. 
2012).  
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Figure 4.1. Lineage relationship of nephron progenitor cells and their derivative 
structures and cells types in the kidney. BC – Bowman’s capsule. Adapted from Little 
and McMahon 2012.  
 
 
The Wilms’ Tumour Suppressor-1 (Wt1) gene, which encodes a DNA- and RNA 
binding nuclear transcription factor (Haber et al. 1993, Rivera and Haber 2005), is well 
characterized as a critical player in kidney development and function. In mice, 
homozygous deletion of Wt1 results in bilateral renal agenesis (complete absence of 
kidney formation), characterized by a primary failure of nephron progenitor cells (NPC) 
to differentiate in response to inductive signals from the UB (Kreidberg et al. 1993, 
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Kreidberg 2002). The expression of Wt1 is essential for nephrogenesis as well as 
maintenance of renal function in the adult (Guo et al. 2002). WT1 has also been 
identified as having a central role in podocyte differentiation, and almost half of the 
podocyte specific genes identified by a chromatin immunoprecipitation coupled to 
microarray (ChIP-chip) analysis are direct targets of WT1 (Lefebvre et al. 2015). 
Nevertheless, the molecular mechanisms that mediate Wt1 function in the developing 
kidney remain largely undefined. 
 
In an effort to understand the role of WT1 in the kidney, ChIP-chip analysis identified 
all three members of the Sry-related high mobility group (HMG) box (Sox)-C subfamily 
(composed of Sox4, Sox11 and Sox12) of nuclear transcription factors as novel WT1 
target genes in the embryonic mouse kidney (Hartwig et al. 2010). In the absence of 
Sox4 in NPC (Sox4nephron-), a significant reduction in nephron endowment is observed 
along with a marked thickening of the GBM and extensive podocyte foot process 
effacement. Further, these mice develop severe proteinaceous kidney injury within 2 
weeks of birth, leading to end-stage renal disease. 
 
In this study reduced nephron endowment in Sox4nephron- mice results from the formation 
of fewer pretubular aggregates, likely as a result of decreased cell cycling of nephron 
progenitor cells. As the severity of the phenotype observed in the kidneys of Sox4nephron- 
mice cannot result solely from a reduction in nephron number, the role of Sox4 and 
Sox11 in podocytes was investigated. Conditional deletion of both of these genes 
individually as well as in combination in podocytes were generated using the 2.5P-Cre, 
which expresses Cre recombinase under the control of a 2.5kb fragment of the human 
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NPHS2 (podocin) gene (Moeller et al. 2003). No apparent glomerular phenotype was 
observed after 6 months and integrity of the glomerular filtration barrier was maintained 
in these animals demonstrating that Sox4 and Sox11 are dispensable for normal podocyte 
differentiation and function in vivo. The identification of parietal epithelial cells (PEC) 
extending towards the capillary tuft, along with the presence of multiple layers of PEC 
and increased number of PEC in adult Sox4nephron- glomeruli suggests that the genesis of 
glomerular injury may be the result of activation of PEC. Collectively, these results 
further demonstrate that Sox4 plays an essential role in establishing nephron 
endowment, as well as suggesting a role in regulating the activation of PEC in vivo.  
 
4.3 Materials and Methods 
4.3.1 Mouse Strains  
The Sox4 null (Sox4-) allele (Schilham et al. 1996), conditional Sox4 (Sox4fx) allele 
(Penzo-Méndez et al. 2007), Six2-Cre BAC transgenic line (Kobayashi et al. 2008), 
2.5P/NPHS2-Cre (Podocin-Cre) transgenic line (Moeller et al. 2003) and ROSA26 
reporter strain (Soriano 1999) have been previously characterized. All animal 
experiments were carried out in accordance with the policies of the Animal Care 
Committee at the University of Prince Edward Island and according to the Canadian 
Council on Animal Care guidelines.  
 
4.3.2 Estimation of Glomerular Number 
Glomerular number was estimated using the integrated disector method as described in 
Chapter 3. Briefly, kidneys (n=5 Six2Cre;Sox4fx/- (Sox4nephron-); n=3 wild-type) were 
dissected from male mice at 30 days of age. Kidneys were fixed in 10% neutral buffered 
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formalin (Sigma-Aldrich, St. Louis, MO), processed to paraffin blocks and exhaustively 
sectioned in the sagittal plane at 5µm. Paired sections were collected using a systematic 
uniform random sampling approach, stained with periodic acid-Schiff (PAS), and 
glomeruli were identified and counted. 
 
4.3.3 Explant Experiments 
E12.5 kidneys were dissected out on ice and placed on a 0.4µm pore size cell culture 
insert (Becton Dickinson, Mississauga, ON Canada). The insert was then placed in a 12 
well polystyrene cell culture plate on top of 400µL of improved minimum essential 
medium with Zinc (Gibco, Grand Island, NY) supplemented with 50µg/mL transferrin 
(Gibco). Explants were maintained in the incubator (37°C, 5% CO2) for 72 hours, 
changing the media every 24 hours. Explants were then fixed with cold methanol, 
blocked with 2% Bovine Serum Albumin (Sigma-Aldrich) in 0.1% 
Phosphate-buffered saline (PBS)-Tween (Bio-Rad, Hercules, CA) and stained with 
anti-WT1 (Santa Cruz sc-192) and cytokeratin (Sigma C9687-30). 
 
4.3.4 BrdU and TUNEL Assay 
For BrdU labeling, timed pregnant female mice were injected intraperitoneally with 
BrdU labeling reagent (Roche, Penzberg, Germany),  at a dose of 30μg/g body weight. 
Pregnant mice were euthanized by CO2 overdose and cervical dislocation 1 hour later. 
Kidneys were dissected out and placed in 30% sucrose (Sigma-Aldrich) in PBS 
overnight at 4°C, then flash frozen in Tissue-TEK 4583 OCT compound (Sakura 
Finetek, Torrance, CA) and sectioned at 5μm. Sections were fixed for 20 minutes in 
15mM Glycine Ethanol Fixative with 0.1% Saponin (Sigma-Aldrich), pH 5 at -20°C. 
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Following 3 x 5 minute washes with 0.1% Saponin (Sigma-Aldrich) in PBS, slides were 
treated with DNAse (Roche) for 5 minutes at room temperature, washed 3 x 5 minutes 
with 0.1% Saponin in PBS and incubated with primary antibodies, rabbit α-Six2 1:400 
(Proteintech, Rosemont, IL) and mouse α-BrdU 1:10 (Roche), in incubation buffer at 
room temperature for 1 hour. Following 3 x 5 minute washes with 0.1% Saponin in 
PBS, slides were incubated with secondary antibodies, Alexa594 α-rabbit 1:400 and 
BrdU Kit α-mouse 1:10 for 1 hour at room temperature. Slides were then washed and 
mounted.  
 
For TUNEL labeling frozen sections were generated as above and stained according to 
manufacturer’s instructions (Roche kit) following staining with rabbit α-Six2 1:400 and 
Alexa594 α-rabbit 1:400 (Jackson ImmunoResearch, Westgrove, PA) . For both 
TUNEL and BrdU, a single section down the midline of the embryonic kidney was used 
for quantification. 
 
4.3.5 Histology 
Kidney tissues from adult mice were ﬁxed in 10% neutral buffered formalin and 
processed to parafﬁn blocks. Tissues were sectioned at a thickness of 5 µm and 
subsequently stained with hematoxylin and eosin (H&E) and periodic acid-Schiff 
(PAS). 
 
4.3.6 Transmission Electron Microscopy 
The cortical region of the kidney was trimmed, cut into 2–3 mm thick sections, and 
immediately immersed in 2% glutaraldehyde (SP1 Supplies, West Chester, PA) in 0.1 
M phosphate buffer, pH 7.2, and refrigerated overnight at 4°C. Tissues were washed 
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twice for 10 minutes with 0.1 M phosphate buffer, post-ﬁxed in 1% osmium tetroxide 
(SP1) in phosphate buffer for 2 hr at room temperature, then washed for 10 min in 0.1 M 
phosphate buffer. Tissue was then dehydrated through a graded series of ethanols, 
cleared in propylene oxide (SP1), and inﬁltrated and embedded in Epon 
(SP1). Semi-thin sections (0.5 mm) were cut and stained with 1% toluidine blue in 1% 
sodium tetraborate solution and examined with a light microscope. All samples that 
contained at least two glomeruli were re-cut to generate ultrathin sections (90 nm). 
Ultrathin sections were stained with uranyl acetate and Sato’s lead stain. Sections were 
examined using a Hitachi H7500 transmission electron microscope operated at 80 kV 
and digital images were captured using an AMT XR40 side-mounted camera. 
 
4.3.7 X-Gal Staining 
E16.5 kidneys were dissected out in ice-cold PBS, fixed in 20% formaldehyde (SP1) 
and 2% glutaraldehyde (SP1) for 40 minutes with shaking. Kidneys were then washed 3 
times for 20 minutes in PBS and incubated overnight with staining solution (Sigma) at 
37°C. Embryonic kidneys were then washed 3 times for 20 minutes in PBS and fixed 
overnight in 4% paraformaldehyde (Sigma-Aldrich) at 4°C. Kidneys were then 
processed to parafﬁn blocks. Tissues were sectioned at a thickness of 5 µm, cleared of 
paraffin with xylenes and rehydrated to water through a series of ethanols. Cover slips 
were then mounted with Flo-Texx (Lerner Laboratories, Pittsburgh, PA) and sections 
imaged.  
4.3.8 Statistical Methods  
Comparison of Sox4nephron- and wild-type animals was performed by two sample t-tests 
using Minitab 16. Data are presented as mean ± standard deviation. 
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4.4 Results and Discussion 
4.4.1 Nephron Endowment 
There is a reduction in the number of nephrons, both embryonically and postnatally, when 
Sox4 expression is conditionally ablated in NPC (Sox4nephron-) (Chapter 2 and Chapter 3). 
This reported reduction could be the result of a delay in nephrogenesis rather than a direct 
effect on nephron endowment. In order to confirm the role Sox4 plays in nephron 
endowment, an accurate estimate of nephron number was established in adult male mice 
(post natal day 30) by unbiased stereology using the integrated disector method (Chapter 
3). A significant reduction in nephron endowment (47%) was maintained in adult 
Sox4nephron- mice compared to wild-type controls (Figure 4.2).  
 
 
 
Figure 4.2. Reduced nephron endowment is maintained in adult (postnatal day 30) 
Sox4nephron- kidneys. Glomerular number is significantly reduced in Sox4nephron- mice 
(47%) compared to wild-type (WT) littermates as determined by the integrated disector 
method. Data are Mean ± SD. 
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In an effort to elucidate the genesis of the renal phenotype observed in Sox4nephron- mice, 
the effect of Sox4 deletion on embryonic nephron development was evaluated by 
quantifying the number of nephron precursor pre-tubular aggregates (PTA) in whole 
organ kidney explant cultures. Embryonic day (E)12.5 kidneys were cultured for 72 
hours and PTA were readily identified by WT1 immunofluorescence as large punctate 
structures adjacent to UB (Figure 4.3A). In the mouse, the generative fertilisation of 
multiple oocytes occurs within a given window of time following copulation. However, 
not all embryos in a given litter will be fertilized at exactly the same point in time 
resulting in a slight asynchrony of development among embryonic littermates. In order 
to account for this potential lack of synchronicity at the time of dissection, counts were 
normalized to UB branch points. Although the number of PTA varied greatly in both the 
Sox4nephron- and control explants, a highly significant reduction (47%) was observed in 
the a Sox4nephron- explants compared to wild-type controls (Figure 4.3B). 
 
 
 
Figure 4.3. Embryonic kidney explants exhibit a 47% reduction in pre-tubular aggregate 
(PTA) formation in the absence of Sox4. A) Representative wild-type (WT) and 
Sox4nephron- E12.5 explants after 72 hours in culture. Red: nephron progenitor cells and 
pre-tubular aggregates (WT1). Green: ureteric bud (cytokeratin). B) Quantification of 
PTA normalized to ureteric bud branch points. Data are Mean ± SD. 
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Sox4 is a transcription factor that has been shown to play many roles in various organ 
systems, at times being identified as an inhibitor of apoptosis, while in others 
upregulating apoptosis depending on the cellular context (Vervoort et al. 2013). In the 
absence of Sox4 in SIX2 positive NPC, the decrease in the number of nephrons both 
postnatally and embryonically results from the formation of fewer PTA. In the absence of 
Sox4, SIX2 positive NPC may be affected by an increase in apoptosis, a decrease in cell 
proliferation, a change in cell fate or some combination of the three. 
 
In order to evaluate these possible mechanisms, protocols were established and refined to 
evaluate any effects on cell proliferation and apoptosis. The TUNEL assay was used to 
compare the number of cells undergoing apoptosis between wild-type and Sox4nephron- 
kidneys. No Six2 positive cells undergoing apoptosis were observed and preliminary data 
indicate that no differences in apoptosis in the nephrogenic zone were observed at E15.5 
in the kidneys of conditional knockout embryos compared to controls as quantified by 
TUNEL assay (Figure 4.4A).  
 
The incorporation of BrdU into newly synthesized DNA was used as a proxy marker to 
identify cycling cells and to compare rates of proliferation of Six2 positive cells in 
Sox4nephron- and control kidneys. Reproducibility and consistency of this assay was an 
ongoing issue. Several pilot studies, with small sample sizes, were undertaken using 
variations of the protocol. Overall, the data on all accounts indicated a trend towards a 
decrease in Six2 positive cycling cells in the Sox4nephron- kidneys compared to control 
(Figure 4.4B). The data suggests that the absence of Sox4 in NPC leads to a reduction in 
cell cycling which, in part, results in fewer PTA and lower nephron endowment. 
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However, further refinement of the protocol and larger sampling are required to 
substantiate this finding. Further, in order to assess the possibility that NPC cell fate is 
altered and that proper signaling is not maintained in the absence of Sox4, a panel of 
markers covering the various cellular compartments of the kidney will need to be 
evaluated. 
 
Figure 4.4. Preliminary data indicate that ablation of Sox4 in SIX2 positive nephron 
progenitor cells leads to a significant reduction in cell proliferation with no effect on 
apoptosis in embryonic day (E)15.5 kidneys. A) Left – representative image of SIX2 
and TUNEL staining in wild-type (WT) kidney. Right – Quantification of TUNEL 
positive cells. No significant difference is observed in TUNEL positive cells between 
WT and Sox4nephron- kidneys in the nephrogenic zone. B) Left - representative image of 
Six2 and BrdU immunostaining in WT kidney. Right – Ratio of BrdU+;Six2+ cells/ 
total Six2+ cells indicates a significant reduction in cell proliferation in the absence of 
Sox4. Data are Mean ± SD. 
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4.4.2 Conditional Knockout of Sox4 and Sox11 in Podocytes 
It is clear that in the absence of Sox4 in NPC, mice develop fewer nephrons, however 
this alone would not lead to the death of the animal as a result of kidney failure. 
Although very few indications exist that the kidney can self-repair, it is clear that a 
given number of adaptations take place in the kidney following damage. These have 
been observed and documented in the case of the solitary kidney following a unilateral 
nephrectomy (removal of a single kidney, either due to renal disease or in the case of a 
living kidney donor). In the case of a living donor, the number of nephrons is reduced 
by 50% with the removal of one kidney, as a result the size and function of the 
remaining kidney increases to compensate for the loss. Adaptive compensatory 
phenomena can be observed and include an increase in plasma flow, increased 
glomerular pressure, glomerular hyperfiltration accompanied by increased glomerular 
size and kidney mass (Gluhovschi et al. 2013). The hypertrophy and hyperfiltration 
observed in the remaining nephrons may lead to glomerular basement membrane lesions 
and further progress to proteinuric renal disease. Barring the presence of other disease 
conditions, such compensatory adaptations take years to develop. For this reason, the 
severity of the early-onset proteinuric glomerular injury observed in postnatal 
Sox4nephron- mice, renders a reduction in nephron number alone likely insufficient to fully 
explain the observed phenotype.  
 
The absence of Sox4 in NPC leads to the abrogation of the structure and function of the 
glomerular filtration barrier, which is characterized by a marked thickening of the GBM 
and extensive podocyte foot process effacement (reported in Chapter 2). In wild-type 
mice, Sox4 expression was present in epithelialized nephrogenic structures, including 
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the renal vesicle and putative podocytes (Chapter 2). As podocytes are derived from 
NPC (Figure 4.1), an investigation into the requirement for Sox4 in podocyte 
development and maintenance was warranted. It is possible that a primary defect in 
podocyte development or maintenance could lead to the loss of integrity observed in the 
filtration barrier. However, this could also occur secondary to a primary insult not 
intrinsic to the podocytes. In order to clearly distinguish between these two options, 
Sox4 function was ablated in podocytes (Sox4podocyte-/-) using the 2.5P-Cre, which 
expresses Cre recombinase under the control of a 2.5kb fragment of the human NPHS2 
(podocin) gene (Moeller et al. 2003).  
 
The expression of the Cre recombinase was confirmed by crossing the 2.5P-Cre mice 
with the ROSA26 reporter strain (Soriano 1999) and evaluating LacZ expression 
through β-galactosidase activity in E16.5 kidneys. In the absence of 2.5P-Cre, no 
β-galactosidase activity was detected throughout the kidney and the glomeruli remained 
unstained by X-Gal (Arrows, Figure 4.5). In the presence of 2.5P-Cre, X-gal staining is 
present in all mature glomeruli, confirming previous reports of the specificity and high 
efficiency of Cre excision (Moeller et al. 2003).  
 
In conjunction with the generation of mice lacking Sox4 function in podocytes, an 
evaluation of the role in podocytes of Sox11(Sox11podocyte-/-) and the combined role of 
Sox4/Sox11 (Sox4podocyte-/-;Sox11podocyte-/-) was needed by generating the associated 
conditional and double conditional knockout mice. Mice from all three strains were born 
in the expected Mendelian ratios and no distinctions could be made between wild-type 
and conditional knockouts in regards to size at birth or weight gain over 6 months (data 
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not shown). Kidneys from male littermates were evaluated by light microscopy at 6 
weeks and 6 months of age. No significant changes associated with genotype were 
identified in either Sox4podocyte-/- or Sox11podocyte-/- kidneys when compared to littermate 
controls (data not shown). For the double conditional knockout strain, 5 distinct 
genotypes were evaluated: Sox4podocyte-/-;Sox11 podocyte-/- , Sox4 podocyte-/-;Sox11 podocyte+/-, 
Sox4 podocyte+/-;Sox11 podocyte-/-, Sox4 podocyte+/-;Sox11 podocyte+/-, and wild-type controls. No 
significant changes associated with genotype were identified in any of the 4 genotypes 
of the double conditional knockout strain by hematoxylin and eosin or PAS staining 
when compared to littermate controls at 6 weeks (data not shown) and 6 months (Figure 
4.6). All microscopic findings were reviewed by a board-certified (American College of 
Veterinary Pathologists) veterinary pathologist. 
 
Evaluation of the structure of the glomerular filtration barrier and podocytes was carried 
out by transmission electron microscopy. At 6 months of age, no significant differences 
associated with genotype were observed in any of the genotypes evaluated. Podocyte 
structure and foot processes were conserved, slit diaphragms were present and GBM 
thickness was maintained in the absence of Sox4 (Figure 4.7A), Sox11 (data not shown) 
and Sox4/Sox11 (Figure 4.7B) in podocytes. Although Cre was properly expressed, as 
determined by ROSA26 reporter strain, no apparent glomerular phenotype was observed 
after 6 months and integrity of the glomerular filtration barrier was maintained. As it has 
previously been shown that Sox4 expression is significantly reduced in the adult kidney, 
it was hypothesized that the primary role of Sox4 in the kidney is during embryonic 
development. The phenotype observed in Sox4nephron- kidneys is likely the result of 
congenital defects further aggravated by a significant decrease in nephron number which 
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ultimately leads to end-stage kidney disease (ESKD). It has been demonstrated here that 
the absence of Sox4 expression in podocytes does not recapitulate the phenotype 
 
 
 
Figure 4.5. Enzymatic X-gal staining confirms expression of 2.5P-Cre in podocytes of 
the developing kidney. A) Whole kidneys stained with X-gal at E16.5. Left – in the 
absence of the 2.5P-Cre transgene, kidney remains unstained, while in the presence of 
the transgene (middle and right kidney) glomeruli stain blue (arrows). B) 5µm sections 
of kidneys in A. Left – in the absence of the 2.5P-Cre transgene, mature glomeruli 
(arrows) remain unstained, while in the presence of the transgene (right) glomeruli stain 
blue.  
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Figure 4.6. Adult Sox4podocyte-/-/Sox11podocyte-/- (6 month) kidneys are indistinguishable 
from wild-type (WT) controls. H&E and PAS staining of the renal cortex. 
 
 
previously reported when Sox4 expression is abrogated in NPC, and that the integrity of 
the glomerular filtration barrier is maintained. The observed phenotype must therefore 
be secondary to a primary effect in a cell type derived from NPC that is not the 
podocyte.  
4.4.3 Activation of Parietal Epithelial Cells in Sox4nephron- Mice 
Over the past several decades there has been emerging interest in the study of the 
various resident glomerular cell types. In the 1980s and 1990s, the focus was on 
mesangial and endothelial cells, followed by two decades of intense study of the 
development and function of the podocyte. Most recently, parietal epithelial cells (PEC) 
have taken center stage in glomerular research (Shankland et al. 2014). PEC form the  
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Figure 4.7. Absence of adult (6 months) ultrastructural renal phenotype in A) 
Sox4podocyte-/- and B) Sox4podocyte-/-/Sox11podocyte-/- mice. No podocyte injury or foot 
process effacement can be observed and glomerular basement membrane thickness is 
maintained throughout the genotypes as compared to wild-type (WT). 
 
 
external layer of Bowman’s capsule and present with a sexual dimorphism in mice as 
male PEC consist of a mixture of squamous and cuboidal cells or purely cuboidal cells, 
whereas PEC in females present mostly as squamous cells (Ahmadizadeh et al. 1984, 
Yabuki et al. 1999). PEC and podocytes share a common phenotype until the S-shaped 
body stage, when podocytes start to lose expression of proliferation markers, whereas 
PEC continue to maintain those same markers (Pavenstädt et al. 2003, Ohse et al. 2009). 
Although multiple experiments, including metabolic labeling and lineage tracing of PEC 
in juvenile rats (Appel et al. 2009), have suggested that a portion of podocytes are 
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recruited from adjacent PEC, the hypothesis that PEC can act as podocyte progenitors 
remains controversial (Shankland et al. 2014).  
 
Activated PEC (aPEC) are a subset of PEC exhibiting increased cellular activity, 
proliferation, relatively larger cuboidal cytoplasm, and enlarged nuclei. These cells can 
also exhibit increased thickness of the underlying parietal basement membrane due to 
increased matrix deposition (Shankland et al. 2014). Activated PEC are associated with 
glomerular crescents, where the proliferating PEC form a multilayered crescent that 
eventually will obstruct the tubular outflow, disconnect the glomerulus from its tubule 
and subsequently lead to glomerular degeneration and loss (Le Hir et al. 2001, Le Hir 
and Besse-Eschmann 2003). Progressive glomerulosclerotic lesions can also result 
following the adhesion of an affected capillary to Bowman’s capsule by either aPEC or 
podocytes. The aPEC then invade the glomerular tuft and deposit extracellular matrix 
proteins resulting in loss of podocytes, increased mesangium and development of 
advanced sclerotic lesions (Figure 4.8) (Smeets et al. 2011, Smeets and Moeller 2012).  
 
As PEC are derived from NPC (Figure 4.1), determining if the activation of PEC could 
be responsible for the genesis of ESKD observed in Sox4nephron- mice was explored. 
H&E sections from 13 month old animals were examined. Cells were observed 
extending from the parietal layer towards the capillary tuft (Figure 4.9C), there were 
several instances of multiple layers of cells (Figure 4.9D), and overall there appeared to 
be an increased number of cells in the parietal layer resulting in cells that appeared more 
tightly packed (Figure 4.9E & F) than in wild-type (Figure 4.9A & B).  
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Figure 4.8. Schematic representation of progression to glomerulosclerosis by activation 
of PEC. A) Normal glomerulus with capillaries and mesangium (in black) surrounded 
by podocytes (gray cells) lining the capillary tuft and PEC (white cells) lining the inside 
of Bowman’s capsule (BC). B) Focal activation of PEC (red) and adhesion to the 
capillary. Increased deposition of matrix may also occur on BC (pink matrix). C) 
Activated PEC invade the glomerular tuft (black arrowhead) and deposit matrix. PEC 
can appear disconnected from the adhesion due to sectioning (white arrowhead). 
Sclerosis of the glomerular tuft progresses with mesangial sclerosis developing within 
the affected segment (white arrow). D) Advanced sclerotic lesion in which capillary 
loops are covered by PEC (black arrows) and matrix (pink). Some PEC will no longer 
express markers of activation (white arrows). At the initial site of adhesion, a matrix 
bridge is maintained between BC and the glomerular tuft (black arrowhead). Adapted 
from Smeets et al. 2011. 
 
 
In order to further confirm the activation of PEC in the absence of Sox4 in NPC, 
evaluation of a greater number of glomeruli must be carried out in order to increase 
confidence that the observations of aPEC are not solely due to plane of sectioning. 
Identification of aPEC could also be carried out by staining for CD44 or claudin-1/-2, 
markers of aPEC (Smeets et al. 2011, Shankland et al. 2014). Evaluation of the 
composition of the basement membrane could also serve to indicate PEC activation. The 
GBM, not unlike other basement membranes, is principally composed of networks of 
laminin, type IV collagen, nidogens and heparin sulfate proteoglycans. The isoforms of 
both laminin and type IV collagen in the GBM are known to change with the 
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Figure 4.9. Activation of parietal epithelial cells in 13 month old Sox4nephron- mice. 
Various phenotypic manifestations of activation are observed much more frequently in 
Sox4nephron- mice(C-F) than in wild-type (WT) controls (A-B). Black arrows – cells 
extending (migrating) towards capillary tuft. Arrow head – multiple layers of parietal 
cells. White arrows – increased number of parietal cells, more tightly packed than in 
WT.  
 
development and maturation of the glomeruli. Type IV collagen is composed of triple 
helical heterotrimers. Six distinct collagen IV α chains form only three different 
heterotrimers: α1α2α1(IV), α3α4α5(IV), α5α6α5(IV). The α1α2α1(IV) synthesized by 
the endothelial cells and the podocytes of the immature GBM is replaced by 
α3α4α5(IV), synthesized solely by the podocytes in the mature GBM (Abrahamson et 
al. 2009). α5α6α5(IV) is not detected in the GBM under normal conditions, however it 
is a major component of the basement membrane of Bowman’s capsule (Ninomiya et al. 
1995), and aPEC have also been shown to deposit “Bowman’s capsule type matrix” 
including α1α2α1(IV) atop of the existing GBM (Cai et al. 1996, Smeets et al. 2011). 
102 
 
Thus an analysis of the composition of the GBM thickening observed in Sox4nephron- 
mice could help to ascertain the cellular origin of the increased matrix. Further 
investigation with an additional conditional knockout approach targeting PEC, would 
also increase our understanding of the role of Sox4 in the glomerulus. This could be 
done using the Pax8Cre which targets both the visceral and parietal epithelial cells of 
maturing glomeruli from the late S-shaped body stage as well as UB cells (Bouchard et 
al. 2004, Grouls et al. 2012). Taken together, with data from our Sox4nephron- mice, such 
animals would allow us to better tease out the cellular and molecular mechanisms 
underlying the role of Sox4 in kidney development and maintenance.  
 
In summary, a reduction in cell cycling of NPC was identified as the probable source of 
reduced PTA and subsequent reduced nephron endowment observed in the absence of 
Sox4 in NPC. Sox4 and Sox11 alone and in combination are dispensable for proper 
podocyte differentiation and function. The absence of Sox4 expression in podocytes 
does not recapitulate the loss of integrity of the glomerular filtration barrier observed in 
Sox4nephron- mice. Histological observations suggest that an activation of PEC is present 
in Sox4nephron- mice and could, along with the increased stress due to significant 
reduction in glomerular number, potentiate the genesis of the early-onset proteinaceous 
glomerular injury as well as its progression. Future studies will properly assess the 
activation status of PEC and conditional gene deletion studies will be aimed at 
recapitulating the phenotype observed in Sox4nephron- mice. Additionally, gene deletion 
studies are needed to evaluate the independent role of Sox11, as well as the combined 
role of Sox4/Sox11, signalling during renal development in vivo. 
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5. Conclusions and future directions 
5.1 Summary of Major Findings 
A descriptive analysis of the expression of Sox4 in the developing kidney was first 
performed. The expression of Sox4 is highest in the early stages of developing kidney, 
and lowest in the adult. Sox4 is expressed in nephron progenitor cells (NPC) and ureteric 
bud (UB) and continues to be expressed in differentiated nephrogenic structures just 
prior to birth (E18.5) as detected by in situ hybridization.  
 
Because Sox4 knockout mice die at E14, prior to the completion of nephrogenesis, I 
have employed a conditional knockout approach, using a floxed Sox4 allele 
(Penzo-Méndez et al. 2007) and Six2-Cre (Kobayashi et al. 2008), in order to study the 
role of Sox4 in kidney development. Conditional ablation of Sox4 in the nephrogenic 
lineage (Sox4nephron-) results in post-natal glomerular disease in vivo characterized by 
tubular dilatation, poorly defined glomerular tufts, reduced cellularity of the renal 
corpuscle and disorganization of the filtration barrier, which ultimately leads to end 
stage renal failure by 5 to 9 months of age and death of the animal (Chapter 2). As early 
as 2 weeks after birth, kidneys exhibit numerous periodic acid-Schiff (PAS) positive 
protein casts in dilated tubules. Renal corpuscles were hypocellular and had poorly 
defined glomerular tufts, with an increase in mesangial matrix. These mice also 
exhibited a focal loss of the proximal tubular brush border. A closer look at the 
ultrastructure of the glomerular filtration barrier revealed that in the absence of Sox4, 
glomeruli display extensive podocyte foot process effacement and a thickening of the 
glomerular basement membrane (GBM). By P7 glomeruli also exhibited a reduction in 
the slit diaphragm protein nephrin and a reduction in the number of Wt1+ podocyte 
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nuclei suggesting that Sox4 may play a role in podocyte development and maintenance.  
Further Sox4nephron- mice exhibit a reduction in nephron number. This was first observed 
anecdotally as the histological slides were examined and then quantified using the acid 
maceration technique. I was able to accurately confirm this fact both embryonically and 
post-natally by adapting the gold standard physical disector/fractionator method for 
glomerular quantification. In an effort to understand the origin of reduced nephron 
number, explant experiments were carried out on embryonic kidneys and revealed that 
the reduced nephron endowment in Sox4nephron- mice results from the formation of fewer 
pretubular aggregates (PTA). I further sought to investigate if the formation of fewer 
PTA resulted from increased apoptosis, decreased proliferation or a change in cell fate 
of NPC. Preliminary data indicate no changes in apoptosis and a decrease in cell 
proliferation of NPC in Sox4nephron- kidneys.  
 
Research continues to further elucidate the molecular mechanisms involved in kidney 
development, and many of the steps required to build a kidney have been identified. 
However, in a more general sense, what determines if a human kidney will develop 
300,000 or 1,000,000 nephrons has not been identified. Although the precise molecular 
mechanisms of the observed phenotypes require further investigation, I have presented 
here definitive evidence that Sox4 is essential for proper nephron endowment. I have 
also established the integrated disector method as an updated adaptation of the gold 
standard physical disector/fractionator method for unbiased estimation of glomerular 
number (Chapter 3).  
 
A reduction in nephron number alone would be insufficient to explain the severity of the 
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phenotype observed in Sox4nephron- mice. To further pursue the hypothesis that Sox4 is 
essential in podocyte development and maintenance I generated a conditional knockout 
strain of Sox4 in podocytes (Sox4podocyte-/-). The absence of Sox4 expression in podocytes 
does not recapitulate the Sox4nephron- phenotype and the integrity of the glomerular 
filtration barrier is maintained. The observed phenotype in Sox4nephron- mice must 
therefore be secondary to a primary effect in a cell type derived from NPC that is not the 
podocyte. Finally, I have presented preliminary data to suggest a second role for Sox4 in 
the kidney as a potential repressor of parietal epithelial cell activation (Chapter 4).  
 
5.2 Future Directions 
The research presented herein clearly demonstrates that the null hypothesis “Sox4 is not 
required for normal murine kidney development in vivo” must be rejected. Although 
much progress has been made into understanding the role of Sox4 in kidney development, 
as with most research, more questions than answers remain. Multiple approaches were 
used to address the role of Sox4 in kidney development, not all of them presented in detail 
in this thesis. Multiple compartments and cell types were targeted using the conditional 
knockout approach (APPENDIX E, F). For various reasons not all models were studied in 
detail. A summary table of mouse models evaluated over the course of the presented 
thesis and studied by the author can be found in APPENDIX G. Because Sox4 knockout 
mice die prior to the completion of nephrogenesis, observations were also made with 
Sox4-/- embryonic kidneys at E13.5 and E14.5 just prior to embryonic death. An increased 
prevalence of glomerular dilatation compared to wild-type controls was observed at 
E14.5 (APPENDIX H). To further the study of Sox4 in the kidney, other simple 
experiments using Sox4-/- embryonic kidneys could help complete the story. If explant 
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experiments with Sox4-/- kidneys recapitulate the decrease in number of PTA observed, 
this would increase the strength of the observation that the primary role is in NPC. 
However, a clear indication of the role Sox4 is playing would be more difficult to interpret 
in this system as Sox4 expression would be absent in all lineages. A more severe 
phenotype could indicate complementary roles in cross signaling with the UB and other 
cell types. While a less severe phenotype could indicate that Sox4 is playing an opposing 
role in the UB, such as to reduce signaling from the UB to NPC.  
 
Observations in Sox4-/- embryos also led me to discover an elongated gonad phenotype 
(APPENDIX I). This phenotype was also observed in the Pax3Cre conditional knockout 
of Sox4 (data not shown). Later, in collaboration with Dr. Peter Koopman’s group, I was 
able to confirm this observation in the Sox4-/- embryos (APPENDIX J). 
 
Reduction in nephron number in the absence of Sox4 in NPC may be the first insult 
leading to the end-stage kidney disease (ESKD) phenotype. A compensatory 
hyperfiltration and hypertrophy of the nephrons can result in increased stress of the 
glomerular environment and heightened susceptibility to injury and insult. I was not able 
to definitively identify the cell type causing primary injury, however it is clear from the 
data presented herein that Sox4 is dispensable in podocytes. The majority of glomerular 
diseases can be associated with segmental or global glomerular scarring, regardless of 
which glomerular cell type is primarily injured (Shankland et al. 2014). Local podocyte 
damage can also spread to induce injury in otherwise healthy podocytes and further 
affect glomerular endothelial and mesangial cells (Ichikawa et al. 2005). 
 
It is also possible that the primary role of Sox4 is in the maintenance of the proximal 
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tubule. Sustained injury to the proximal tubule can also result in interstitial fibrosis. 
Others have shown that this is then followed by capillary loss and glomerulosclerosis as 
well as distal tubule injury, indicating a cross talk between proximal and distal tubule as 
well as between proximal tubules and fibroblasts (Grgic et al. 2012, Takaori et al. 2016). 
It has also been shown that proximal tubule injury leads to cell cycle arrest of epithelial 
cells and activation of signaling pathways that activate pro-fibrotic gene transcription, 
resulting in vascular rarefaction, myofibroblast proliferation and extra-cellular matrix 
deposition in the interstitium (Bonventre 2014a, 2014b). Prolonged stress and injury to 
tubular epithelial cells, can result in the release of circulating factors via inflammatory 
cells which can lead to podocyte detachment, effacement and apoptosis (Leung et al. 
2014). This should also be further investigated. Generally speaking, glomerular injury is 
usually seen before tubular injury. It is albeit, tubular injury and increased protein 
trafficking across tubules that results in the irreversible tubulointerstitial fibrosis that 
ultimately leads to ESKD (Leung et al. 2014) 
 
The Sox genes are transcription factors and as such, a primary mechanism of action of 
SoxC in the developing kidney will be to modulate the expression of other genes. The 
Sox family of genes all contain a highly conserved high-mobility group (HMG) domain 
which binds the minor groove of DNA and recognizes the consensus sequence 
A/TA/TCAAA/TG (Wilson and Koopman 2002). In order to confer specificity to gene 
modulation by Sox genes, interaction with protein partners are required (Kamachi et al. 
2000). This model explains how, based on protein partner pairing, the same SOX 
protein can differentially affect gene expression in various cell types, as well as in the 
same cell type at different stages. Sequences recognized by the HMG domain of the 
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SOX proteins, in combination with other sequences recognized by interacting protein 
partners, confer larger specificity to target sequences and modulation of specific genes 
(Kondoh and Kamachi 2010). Identification of SOXC interacting protein partners will 
be key to understanding the role they play in the developing kidney. Identification of 
SOX4 target genes through techniques such as RNA-Seq will also be crucial in further 
elucidating the mechanism of action of Sox4 in the kidney. The continued identification 
and understanding of fundamental processes which underlie the development of a 
functioning kidney is essential. Herein I have presented my contribution to our 
understanding of kidney development in hopes that some day it may further our 
understanding of the etiology of kidney disease and potentially to the identification of 
new therapeutic targets.  
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APPENDIX A – Absolute copy number for each SoxC gene. Copy number for each 
gene was normalized to the absolute copy number of Pgk1 for each sample.  
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APPENDIX B – Expression of Sox4 remains high postnatally. Absolute copy number of
Sox4 gene expression was established and normalized to absolute copy number in the adult. Al-
though a reduction in expression is observed at embryonic day (E)18.5, expression remains at
levels similar to those observed in early embryonic time points after birth before a significant re-
duction is observed between postnatal day (P)9 and P14.
115 
 
 
APPENDIX C - Minimum Information for Publication of Quantitative Real-Time 
PCR Experiments (MIQE) technical information. 
Sample/Template Details 
Source Materials and Methods: Kidneys from CD1 mice 
Method of preservation 
Materials and Methods: RNAlater (Ambion, 
Austin, TX) 
Storage time (if appropriate) 
Materials and Methods: Tissues were stored at 
-80°C for < 2 months. RNA was stored at -80°C 
and reverse transcribed within two weeks. cDNA 
was stored at -40°C and analyzed within 3 months. 
Handling Frozen, see “Storage Time”.  
Extraction method 
Materials and Methods: RNAqueous-4PCR Kit 
(Ambion) 
 RNA: DNA-free 
DNAse step using DNA-free (Ambion) in 
preparation protocol. For each cDNA sample a 
“Minus RT Control” was also prepared.  
Concentration 
Concentration of all RNA preparations were 
quantified using a Nanodrop 1000 
(ThermoScientific). 
RNA: integrity 
Integrity of all RNA preparations were assessed by 
gel electrophoresis and spectral absorption ratios. 
Inhibition-free 
A representative set of 7 samples was used to test 
for the absence of inhibitors by dilution series.  
Assay optimisation/validation   
Accession number 
Sox4 (NM_009238.2), Sox11 (NM_009234.6), 
Sox12 (NM_011438.2) 
Amplicon details 
Amplicon sizes: Sox4 (106bp), Sox11 (129bp), 
Sox12 (82bp). 
Primer sequence Materials and Methods 
Probe sequence* N/A 
In silico 
Specificity of all primers were validated by BLAST 
analysis 
empirical 
Materials and Methods:  All primers were used at 
a concentration of 300nM and annealing 
temperatures were 57°C or 60°C. PCR product 
specificity was determined by melt curve analysis 
following each run using a heating program from 
72°C to 95°C in 1 degree steps with a 5 second 
hold per step. 
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Priming conditions 
For cDNA synthesis oligo-dT primers were used 
as provided with the SuperScript III First-Strand 
System (Invitrogen). 
PCR efficiency 
Materials and Methods: Efficiencies were 
determined using dilution series of kidney cDNA. 
Sox4 Efficiency = 0.96, R2 = 0.998; 
Sox11 Efficiency = 0.99, R2 = 0.999; 
Sox12 Efficiency = 0.93, R2 = 0.999. 
Linear dynamic range 
Spanning unknown targets as determined by 
dilution curves of cDNA as well as 7 samples from 
3 x 106  to 300 copies of plasmid DNA for Sox4, 
Sox11, Sox12  
Limits of detection LODs were not determined in this study. 
Intra-assay variation 
Intra-assay variations of technical triplicates for all 
samples resulted in a Ct standard deviation <0.16 
cycles 
RT/PCR   
Protocols 
Materials and Methods. Reactions were prepared 
with 5μL of cDNA, 300nM of each primer and 
PerfeCta SYBR Green FastMix (Quanta 
Biosciences) in a final volume of 25μL and run in 
triplicate. Cycling conditions were 95°C for 15 
minutes; 46 cycles of 95°C for 15 seconds (s), 57°C 
(Sox11) or 60°C (Sox4 and Sox12) for 30 s, and 
72°C for 30 s. 
Reagents Materials and Methods.  
Duplicate RT 
The RT step was not performed in duplicate in this 
study.
NTC 
A NTC sample was included with each run. No 
amplification was observed in all but two runs, in 
which Ct for NTCs were detected >10 cycles after 
any sample.  
NAC 
Positive control 
Plasmid DNA samples were used as inter-run 
calibrators. 
Data analysis   
Specialist software 
Data was analysed using RotorGene6 software 
(Corbett Research, Sydney, Australia) 
Statistical justification N/A 
Transparent, validated normalisation N/A  
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APPENDIX D – General steps for disector counts using TrakEM2  
  
  
1. Import images as a single stack  
a. File> Import > Image Sequence…  
  
  
  
b. Select folder with reference and lookup sequence and select “Use 
virtual Stack” in order to save on memory.   
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2. Open TrakEM2 environment  
a. File> New> TrakEM2 (blank)   
*later a template can be created to save some time and the 
TrakEM2 (from template) option can be used *  
 
3. Set up the Template and Project Objects (dissector, area_lists, etc.)  
a. Create a template with the items to be used in the TrakEM2 project  
  
  
b. Create child nodes for each of the object categories  
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c. Add a disector to each object category  
  
  
  
  
  
 
  
d. Drag and drop items from the “Template” area to the “Project 
Objects” area   
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e. Disectors can be renamed to distinguish them in the TrakEM2 
environment  
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4. Import the image sequence into TrakEM2  
  
  
  
  
  
 
5. Align the layers manually or automatically  
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6. Identify disector particles, points or other using the disector tool by first 
selecting it in the  
“Z space” tab. Be sure to use the PEN tool  
a. Marks in the previous layer appear in red, and marks in the next 
layer appear in blue and marks in the current layer appear yellow.   
b. Useful keyboard shortcuts in the TrakEM2 environment  
i. <, > used to switch between layers    
ii. -, + to zoom in and zoom out  
iii. With the left mouse button:  
1. Click outside any existing marks to add a new 
mark, starting a new item to count.  
2. Click on the red or blue ghost of a mark to add a 
new mark for that item.  
3. Drag to move a mark. iv. With the click-wheel you 
can click and drag to navigate the current image 
layer or use the “Navigator Panel”  
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7. Generate reports  
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For more details and tutorials see the users manual of TrakEM2 
http://www.ini.uzh.ch/~acardona/trakem2_manual.html  
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APPENDIX E – Target compartments of conditional knockout approaches. These 
conditional knockouts were attempted and generated, and indicated along with their 
derivatives. Adapted from Little and McMahon 2012.  
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APPENDIX F - Mating schemes used to generate mouse models.  
Circles represent females, squares represent males, elongated hexagons are desired 
experimental units. Curved arrows indicate maintenance matings. 
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APPENDIX G – Summary table of mouse models evaluated over the course of the presented thesis 
Mouse line and 
description 
Target compartment Objective Brief summary of results & future work 
Sox4+/- 
 
N/A – Total KO Evaluate the role of 
Sox4 in the kidney 
prior to embryonic 
lethality.  
In our hands the Sox4-/- embryos start resorbing at E14.5, by E15.5 
no structures or cell types can be distinguished. Limited exploration 
of kidney development was carried out by examining embryonic 
kidneys stained for light microscopy. Some glomerular dilatation 
was observed in the KO compared to WT (See Appendix H).  
 
It is also in these animals that the elongated gonad phenotype was 
observed (see Appendix I) and a collaboration with Dr. Peter 
Koopman’s group was established.  
 
Other simple experiments could be performed and comparison to 
Six2Cre conditional KO could further our understanding of 
mechanism such as e12.5 kidney explants for PTA counts and 
assessment of cell cycling.   
 
 
Six2Cre 
 
 
 
 
 
 
 
 
 
Nephron progenitor 
cells (NPC) 
Evaluate the role of 
Sox4 and Sox11 in 
NPC 
Sox4 is essential for proper nephron endowment, and kidney 
development. In the absence of Sox4 in NPC, mice die of kidney 
failure.  See Chapters 2, 3, and 4 for details.  
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Pax3Cre Metanephric 
mesenchyme 
Evaluate the role of 
Sox4 and Sox11 in the 
metanephric 
mesenchyme (from 
E11.5) and its 
derivatives (NPC and 
stromal progenitors). 
Crosses were started in conjunction with the Six2Cre crosses. 
Inconsistencies in phenotype penetrance and association with 
genotype was observed. Obtained 3 animals in long term study with 
unilateral hydronephrosis. Variations in phenotype possibly due to 
mosaicism of Cre expression. Once clear phenotype of SixCre 
model emerged, Pax3Cre was put to the side.  
 
Pax3 is also expressed at high levels in the genital ridges at E10.5. 
The elongated gonad phenotype observed in Sox4-/- embryos was 
recapitulated in the Pax3Cre model.  
 
 
Rarb2Cre Metanephric 
mesenchyme 
Evaluate the role of 
Sox4 and Sox11 in 
the metanephric 
mesenchyme (from 
E10.5) and its 
derivatives. Compare 
phenotype to that of 
Six2Cre.  
Attempted for multiple generations to generate conditional KO of 
Sox4 using this Cre. Issues with litter size, consistently small 
consisting of only 2-4 very large pups, usually born after 20 days 
rather than 19. Outcrossed to CD1 for 3 generations to see if we 
could overcome the issue without any success. Personal 
communication with several individuals who have used the line 
confirmed that this is a known issue with the line, and it takes a 
long time to obtain sufficient animals. Following a cost benefit 
analysis decided to no longer maintain the line in-house.  
 
 
PodCre 
 
 
 
 
 
 
Podocytes Evaluate the role of 
Sox4 and Sox11 in 
podocytes.  
  
 
 
The absence of Sox4 in podocytes does not recapitulate the Six2 
phenotype. See Chapter 4 for details.  
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SF1Cre Somatic cells of 
gonads of both sexes 
Attempt to 
recapitulate and 
further evaluate the 
role of Sox4 in gonad 
development 
At 6 weeks of age gonads appeared normal. As it is not the primary 
focus of our group, crosses were discontinued.  
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APPENDIX H – Glomerular dilatation is observed more frequently in Sox4-/- 
kidneys compared to wild-type control littermates at embryonic day (E)14.5 by 
H&E staining. Arrows indicate glomeruli (top), with higher magnification of a single 
glomeruli also shown (bottom).  
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APPENDIX I – Initial gonad elongation phenotype observed in Sox4-/- embryos at 
embryonic day (E)14.5. Phenotype was observed in both female (XX) and male (XY) 
embryos. The male phenotype was more actively pursued as it was more striking and 
resembled a possible ovotesti phenotype. The phenotype was also recapitulated with the 
Pax3Cre conditional KO of Sox4 
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APPENDIX J – In the absence of Sox4 there is an increase in gonad length while 
kidney size is maintained. A) representative images of male (XY) and female (XX) 
gonads and kidneys. B) Length measurements of fetal gonads indicate a significant 
increase in length for both male and female gonads. C) No significant difference is 
observed in length for male or female embryonic kidneys. Bar = 0.5mm.  **P<0.01 
(Liang Zhao) 
 
 
 
